Expired Funding Opportunities

• Internal Selection Competitions
• Internal Opportunities
• NIH
• NSF
• Other HHS Funding Opportunities
• Centers for Disease Control and Prevention
• Department of Defense Sponsored Funding
• Department of Homeland Security
• NASA
• USDA
• USAID
• Department of State
• Department of Justice
• Department of Labor
• EPA
• Health Resources and Services Administration
• IARPA
• Agriculture and Food Research Initiative
• Veterans Health Administration
• National Council on Disability
• NIST
• Non-federal Opportunities
• Return to Open COVID Funding Opportunities

Internal Selection Competitions

Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS=CoV-2 (WUSTL Key required)
Internal Selection deadline is 8/20/2020 (STILL OPEN); Applications due to NIH 09/18/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• Specifically, this FOA seeks to use developed technologies for single vesicle or exosome isolation and analysis and reposition these technologies for the detection of SARS-CoV-2. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Emergency Awards: RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (WUSTL Key required)
Internal Selection deadline is 08/20/2020 (STILL OPEN); Applications due to NIH 09/18/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• Specifically, this FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e., scents or odors) emanating from skin or exhaled breath, saliva and different oral tissues from the oral cavity. These sensing devices must be able to associate VOC patterns to patients with symptomatic and asymptomatic COVID-19. These devices are expected to actively detect VOCs from skin and oral cavities of COVID-19 patients, without being invasive, or affecting the integrity of the skin and oral cavity. For VOC monitoring, these sensing devices can be Electronic-nose (E-nose) technology or Gas Chromatography (GC). Therefore, this program is called SCENT, which stands for Screening for COVID-19 by Electronic-Nose Technology. This FOA seeks to advance novel biosensing technologies that are innovative, safe, and effective using integrated artificial intelligent, pattern recognition and machine learning systems that would make it possible for the detection, diagnosis, prediction, and monitoring of COVID-19 in clinical, community and everyday settings.
• This FOA requires multidisciplinary collaborations to ensure project success. Disciplines may include: biomedical engineers, material scientists, biosensing experts, software engineers, chemists, dentists, clinicians, virologists, clinical trialists, biostatisticians, data analysts and/or other relevant experts in academia and industry. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020

Monitoring Cause-specific School Asenteeism for Estimating Community-wide Influenza and SARS-CoV-2 Transmission (WUSTL Key Required)

Internal Selection Deadline is 10/15/2020 (OPEN); Applications due to CDC 12/18/2020

• The purpose of this notice of funding opportunity (NOFO) is to support a research project that aims to develop and implement an influenza-like illness (ILI)-specific student absentee monitoring system in kindergarten through twelfth grade (K-12) schools and assess its usability for early detection of influenza, SARS-CoV-2, and other respiratory pathogen transmission in schools and surrounding communities. To achieve this aim, the project team will: 1) rapidly determine the causes of school absenteeism in students across selected school district(s) over a three-year period; 2) detect within-household transmission of influenza and SARS-CoV-2 in households from which a student has been absent from school due to ILI; and 3) assess comparability between influenza-specific and SARS-CoV-2-specific student absenteeism data from the participating schools and multiple layers of complementary influenza and SARS-CoV-2 surveillance data routinely collected in the health care facilities serving the general population of this school district
• Estimated Total Program Funding is $3M; Award Ceiling is $1M; Award Floor is $500,000.

US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children (RFA-IP-21-002) (WUSTL Key required) Internal Selection deadline is 12/07/2020 (STILL OPEN); Applications due to CDC 02/8/2021; LOIs due to CDC 01/7/2021.

HRSA National Telehealth Resource Center program (HRSA-21-023) (WUSTL Key required) Internal Selection deadline is 11/12/2020 (OPEN); Applications due to HRSA 01/21/2021.

HRSA Regional Telehealth Resource Center Program(HRSA-21-022) (WUSTL Key required) Internal Selection deadline is 11/12/2020 (OPEN); Applications due to HRSA 01/21/2021.

DOS The Global Equality Fund (WUSTL Key Required) Internal Selection deadline is 12/21/2020 (OPEN); Applications due to DOS 02/05/2021.

CDC Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services (RFA-GH-21-004) (WUSTL Key required) Internal Selection deadline is 12/07/2020 (STILL OPEN); Applications due to CDC 02/18/2020; LOIs due to CDC 01/18/2021.

DOS Counter Misinformation and Disinformation about COVID-19 (US Mission to Poland) (WUSTL Key required) Internal Selection deadline is 02/01/2021 (OPEN); Application due to DOS 02/28/2021

Christopher and Dana Reeve Foundation Quality of Life Grants – COVID-19: Addressing Social Isolation Grants (WUSTL Key Required) Internal Selection deadline is 02/11/2021 (STILL OPEN); Applications due to Foundation 03/15/2021

NEH American Rescue Plan: Humanities Organizations​ (WUSTL Key Required) Internal Selection Deadline is 04/19/2021 (OPEN); Application due to NEH 05/14/2021. 

T​he purpose of this emergency relief program is to assist institutions and organizations working in the humanities that have been adversely affected by the coronavirus pandemic. Applicants may propose new humanities projects or focus on sustaining core humanities programs and activities.

Local Community-Based Workforce to increase COVID-19 Vaccine Access (HRSA-21-140) (WUSTL Key Required)

Internal Selection Deadline is 06/01/2021 (OPEN); Application due to HRSA 06/09/2021

• The purpose of the program is to establish, expand, and sustain a public health workforce to prevent, prepare for, and respond to COVID-19. This includes mobilizing community outreach workers, which includes community health workers, patient navigators, and social support specialists, to educate and assist individuals in accessing and receiving COVID-19 vaccinations. This includes activities such as conducting face-to-face outreach and reaching out directly to community members to educate them about the vaccine, assisting individuals in making a vaccine appointment, providing resources to find convenient vaccine locations, assisting individuals with transportation or other needs to get to a vaccination site. The program intends to address persistent health disparities by offering support and resources to vulnerable and medically underserved communities, including racial and ethnic minority groups and individuals living in areas of high social vulnerability.
• HRSA will fund recipients that have demonstrated experience and expertise in implementing public health programs, particularly in medically underserved areas. Award recipients will need to clearly describe how the funding will directly serve and impact vulnerable communities; and demonstrate how they will prioritize hiring individuals from the communities they will serve by providing outreach, education and assistance related to the COVID-19 vaccine.
• This program will focus on providing resources to local and/or regional community-based organizations (CBOs). CBO applicants may engage as individual organizations or create a network of multiple eligible organizations partnering together to complete program activities (i.e. one award recipient with multiple subrecipient organizations).

Internal Opportunities

Institute for Public Health
Letter of Intent due 4/3/20

ICTS COVID-19 Research Funding Program
Applications due 5/11/20

McDonnell Academy RFA Infectious Diseases and COVID-19:  Addressing Challenges to Public Health and Society Through Global Collaboration
Applications due 6/01/2020

NIH Director’s Emergency Early Independence Awards (RFA-RM-20-021)​ (WUSTL Key required)
Internal Selection deadline is 7/7/20. Applications due to NIH 9/4/20

• Early Independence Awards from CARES Act funding that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics

Data.org Inclusive Growth and Recovery Challenge (WUSTL Key required)
Internal Selection deadline is 6/8/2020. Applications are due 7/17/20

• Data.org, in partnership with the Mastercard Center for Inclusive Growth and The Rockefeller Foundation, invites applications to its Inclusive Growth and Recovery Challenge seeking breakthrough ideas that harness the power of data science to help people and communities thrive especially in the wake of COVID-19’s economic impact. Up to 10 awards with a combined total of up to $10 million may be made. Eligibility is unrestricted

ASPiRE D&I Pilot Research Program (We are also inviting applications that examine the impact of COVID-19  on tobacco control policy.)
Applications are due August 1, 2020

RADx-UP – Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Applications are due 8/7/20 or 9/8/20

• This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. Eligible existing grants that can be revised in response to this NOSI are limited to eligible non-fellowship active research and resource grants and cooperative agreements; see the NOSI for details. Apply via PA-20-135

RADx-UP – Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Applications are due 8/7/20 or 9/8/20

• This Notice of Special Interest (NOSI) highlights the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. Eligible existing grants that can be revised in response to this NOSI are limited to eligible non-fellowship active research and resource grants and cooperative agreements; see the NOSI for details. Apply via PA-20-135

Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-012)
Applications will be accepted on a rolling basis through 8/17/20

• The National Center for Complementary and Integrative Health (NCCIH) announces the availability of funds for Administrative Supplements or Urgent Competitive Revisions to promote research on the effects of natural products alone or in combination with other complementary and integrative health approaches on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NCCIH is particularly interested in projects focusing on the therapeutic and/or mechanistic effects on SARS-CoV-2/COVID-19 of natural product–based complementary remedies including, but not limited to: herbal therapies, vitamins, supplements, probiotics, microbial therapies, and Chinese medicine herbal preparations.

The Institute for Informatics (I2) and the Healthcare Innovation Lab are sponsoring a “spin-off” Big Ideas Grant Program
Applications due 10/09/2020; Grant winners notified 10/19/2020

• This grant provides an opportunity for teams to secure funding for COVID-19-related informatics and care delivery innovations. Applicants may request up to $50,000. Supports novel and innovative projects that are clinically relevant, technically feasible, and operational sustainable.
• Teams must be co-led by a BJC employee and a WUSM faculty member. Project teams should consist of members with relevant clinical, investigative and operational skills. WUSM/BJC collaboration is required.
• Big Ideas COVID info Sheet
• Big Ideas COVID flyer

Identifying and addressing the challenges of COVID-19 through artificial intelligence, technology, and big data (McDonnell International Scholars Academy and Social Policy Institute (SPI))

• Deadline is February 26, 2021
• The McDonnell International Scholars Academy and the Social Policy Institute (SPI) at Washington University in St. Louis are seeking proposals from Washington University researchers and international partners that identify and address the challenges of COVID-19 through artificial intelligence, technology, and big data. This is the second year the Social Policy Institute and McDonnell Academy have partnered to provide seed grants for international research. SPI’s focus on cross-sector collaboration and international research is a natural complement to the McDonnell Academy’s emphasis on incubating domestic and international research talent and strengthening Washington University’s global profile. As such, this joint seed grant program will capitalize on the strengths of both institutions and further establish Washington University as a leader in global research.
• Funding provided in part by the Mastercard Impact Fund, in collaboration with Mastercard Center for Inclusive Growth.
• The McDonnell Academy’s network of premier partner universities can help to facilitate joint research. Proposed projects are encouraged to include an international collaborator from any of the McDonnell Academy’s partner universities, and can include other institutions as well. Preference will be given to projects that also foster collaborations across disciplines.
• Seed grants are available to support faculty research responsive to this call. We anticipate funding up to three proposals at $25,000 each.

NIH

NIAID/NIGMS Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-AI-20-030)
Applications accepted 4/6/20 – 4/8/20

• NIAID is interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV.
• NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens.

Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 (NOT-GM-20-027)
Applications accepted by 5/4/20

• NIGMS will accept applications for Competitive Revisions to active U24 awards for eligible organizations to rapidly provide pilot or supplementary funds to researchers studying the development of predictive models for the spread of SARS-CoV-2 and outcomes of possible COVID-19 public health intervention measures in order to accelerate such research.

NHGRI Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-HG-20-030)
Applications accepted 4/1/20 – 5/15/20

• NHGRI is interested are genomic studies utilizing generalized approaches that take advantage of human research or model systems to study the consequences of SARS-CoV-2 infection. Funds may be used for the collection of samples from human cohorts of individuals with COVID-19 symptoms or evidence of SARS-CoV-2 infection or controls, and/or development of novel model systems to expose animals and cells to SARS-CoV-2.

NHLBI Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757)
Applications accepted on rolling basis until 5/15/20

• NHLBI encourages the submission of applications for Administrative Supplements and Competitive Revisions to active NHLBI grants to support research on SARS-CoV-2 and heart, lung, and blood COVID-19 disease. Or particular interest are studies that take advantage of human research or unique model systems to study the consequences of SARS-CoV-2 infection.

NLM Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-LM-20-010)
Applications accepted until 6/1/20

• NLM is encouraging the submission of applications for administrative supplements to active NLM R01 grants to address the following research areas of interest: Methods for mining clinical data that can be used to identify or predict presence of COVID-19 in biomedical phenotype data, or other relevant topics such as discovery of risks for infection by SARS-Cov-2 viruses, use of standard terminologies for these viruses in federated health data sets. Additionally,  public health surveillance methods that mine genomic, viromic, health data, environmental data and/or data from other pertinent sources such as social media, to identify spread and impact of SARS-Cov-2.

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-DC-20-004)
Applications will be accepted on a rolling basis from 4/7/20 – 6/1/20

• NIDCD is encouraging the submission of applications for supplements to active NIDCD grants to address the pathology, prevention, diagnosis, sequelae, or treatment of COVID-19 directly related to NIDCD’s mission areas of hearing, balance, taste, smell, voice, speech and language.

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK’s Mission (NOT-DK-20-020)
Notice expires on 6/2/20

• For this funding opportunity announcement, NIDDK is interested in the submission of applications for Competitive Revisions to active grants to elucidate if COVID-19 might provoke or exacerbate noncommunicable gastrointestinal, liver, kidney/urological and metabolic/endocrine diseases in people with HIV (PWH) or worsen the consequences of viral hepatitis coinfection.

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK (NOT-DK-20-018)
Applications accepted until 6/1/20

• NIDDK is particularly interested in the submission of applications for Competitive Revisions to active grants  focusing on the direct action of the virus on kidney, gastrointestinal tract function, and the endocrine/metabolic system, and the collection of biosamples that will inform the understanding of renal, gastrointestinal, and endocrine/metabolic sequelae of viral infection. Pilot clinical studies (observational and interventional) that support the understanding or treatment of COVID-19-related diseases within the mission of the NIDDK are also of interest. NIDDK will only consider applications that propose projects that may lead to rapid translation and impact in the COVID-19 emergency to be responsive to this NOSI.

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
Applications accepted on a rolling basis from 4/15/20 through 6/19/20

• NIH is encouraging the submission of innovative applications for Emergency Competitive Revisions to active Common Fund grants and cooperative agreements. Innovation may be technological or conceptual. Any relevant area of innovative research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics.

Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-043)
Applications accepted on a rolling basis from 4/14/20 through 6/25/20

• NCI encourages small businesses with NCI-funded active SBIR/STTR awards with promising technologies that have a strong potential to be adapted/repurposed for use as a prophylactic, therapeutic or diagnostic tool for SARS-CoV-2 (COVID-19) to submit applications to PA-18-935, Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional).

Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-042)
Applications accepted on a rolling basis from 4/14/20 through 6/25/20

• NCI encourages the submission of applications for urgent competitive revisions or administrative supplements of existing grants to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa. Topics of specific interest to NCI include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer.

NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)(NOT-AI-20-034)
Applications will be accepted on a rolling basis until 3/25/21

• National Institute of Allergy and Infectious Diseases (NIAID) is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19.  Applications must be submitted to PA-20-135 which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.

Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)
Applications are due 7/22/20

• The purpose of the FOA is to establish Serological Sciences Centers of Excellence with the goal of identifying and advancing research opportunities to characterize the immune responses elicited by SARS-CoV-2 viral infection; understanding the mechanisms driving the serological, humoral and cellular immune responses; determining host, genetic, and environmental modifiers of the immune response; determining the serological correlates of disease pathogenesis and protection against future infection; defining access, communication, and implementation barriers related to SARS-CoV-2 serological testing. 

Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)
Applications are due 7/22/20

• The purpose of the FOA is to establish Serological Sciences Research Projects with the goals of: identifying and advancing research opportunities to characterize the immune responses elicited by SARS-CoV-2 viral infection; understanding the mechanisms driving the serological, humoral and cellular immune responses; determining host, genetic, and environmental modifiers of the immune response; and determining the serological correlates of disease pathogenesis and protection against future infection; defining access, communication, and implementation barriers related to SARS-CoV-2 serological testing.

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19) (NOT-OD-20-159)
Notice expires on 8/22/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). NIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). This emergency NOSI provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020. NIH is seeking applications from current NLM R01 awardees that can, in one or two years, enhance public health infrastructure for predicting and monitoring viral disease outbreaks.

Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-082)
Applications will be accepted on a rolling basis through 8/14/20

• NCI announces an opportunity for current NCI funded Principal Investigators whose postdoctoral fellows have temporarily lost stipend support from a non-profit funder because of the COVID-19 global pandemic may apply for an administrative supplement to cover the postdoctoral fellow’s salary plus applicable F&A for the time and effort devoted to the NCI funded grant.

RADx-UP – Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Applications are due 8/7/20

• This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. Eligible existing grants that can be revised in response to this NOSI are limited; see the NOSI for details. Apply via PA-20-135

Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative (NOT-OD-20-144)
NIH plans to publish multiple FOAs as part of the Rapid Acceleration of Diagnostics – Radical (RADx-rad) initiative to support new, non-traditional approaches and new or non-traditional applications of existing approaches addressing current gaps in COVID-19 testing. The FOAs are expected to be published throughout July, and we will accept applications September 2020 for FY21 funding. RFAs will be on the following topic areas:

• Wastewater detection of SARS-COV-2 (COVID-19)
• Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2
• Chemosensory Testing as a COVID-19 Screening Tool
• Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds)
• Multimodal COVID-19 surveillance methods for High Risk Populations in densely populated facilities
• Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity
• Automatic detection and tracing of SARS-COV-2
• Rad-X Data Coordinating Center

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (PAR-20-178, PAR-20-177)
Applications accepted on a rolling basis till 8/14/20

• This is an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is soliciting New R01 and R21 application to better understand SARS-CoV-2/COVID-19, particularly to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly.

Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
Internal Selection deadline TBN, application due to sponsor 8/7/20

• The RADx-UP CDCC will provide overarching support and guidance in the following four domains: (1) Administrative Operations and Logistics, (2) COVID-19 Testing Technology, (3) Community and Health System Engagement and (4) Data Collection, Integration and Sharing. The CDCC will facilitate RADx-UP collaborative research by providing organizational and analytical infrastructure and expertise, supporting data integration and analysis, and coordinating across RADx-UP projects and the NIH-supported RADx initiatives that are developing and validating new COVID-19 testing technologies.

Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed. (RFA-OD-20-014)
LOI due date is 8/21/2020; Application due date is 9/15/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS),for 2019 Novel Coronavirus (COVID-19). This emergency FOA from the National Institutes of Health (NIH) provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• This RFA will support the early stage development of an innovative platform that integrates biosensing with touchscreen or other digital devices to achieve detection and tracing of SARS-CoV-2 in real-time. Projects are expected to demonstrate proof-of-concept of SARS-CoV-2 detection with high sensitivity and specificity, sensor functionality, and automatic detection by touchscreen or other digital devices. To achieve the goal of this FOA, the proposed project needs to be milestone driven and carried out by a multidisciplinary team with complementary expertise.
• The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) RFA-OD-20-021
Applications due date is 9/18/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• The goal of this RFA is to solicit Fast-Track STTR applications to advance development of novel, non-traditional, safe and effective biosensing and detection approaches to identify the current SARS-CoV-2 virus or other biomarkers of the COVID-19 disease for use in outbreaks of COVID-19, as well as for use in future pandemics resulting from unknown viruses.
• The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19)(U01 – Clinical Trials Not Allowed) RFA-OD-20-015
Applications due 09/15/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative. As one of the programs within the NIH Rapid Acceleration of Diagnostics-Radical (RADx-rad) program the RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) FOA will support wastewater-based testing (WBT) surveillance which can provide detailed mapping of the extent and spread of COVID-19. Wastewater testing has been shown to be orders of magnitude cheaper and faster than clinical screening, albeit serving as a complementary approach rather than substituting individual-level testing and screening. The purpose of this FOA is to solicit cooperative agreements both for field studies and for small business research and development projects in the field of WBT, to address topics such as: investigation and demonstration of specific approaches aiming to increase sensitivity and to inform and optimize sample collection; implementation and development of optimized approaches to extrapolate estimation of population-level data within the community; development of optimized intervention strategies, and incorporation of computational, statistical, and mathematical models.
• The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS=CoV-2 (WUSTL Key required)

Internal Selection deadline is 8/20/2020 (STILL OPEN); Applications due to NIH 09/18/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• Specifically, this FOA seeks to use developed technologies for single vesicle or exosome isolation and analysis and reposition these technologies for the detection of SARS-CoV-2. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Emergency Awards: RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (WUSTL Key required)

Internal Selection deadline is 08/20/2020 (STILL OPEN); Applications due to NIH 09/18/2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• Specifically, this FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e., scents or odors) emanating from skin or exhaled breath, saliva and different oral tissues from the oral cavity. These sensing devices must be able to associate VOC patterns to patients with symptomatic and asymptomatic COVID-19. These devices are expected to actively detect VOCs from skin and oral cavities of COVID-19 patients, without being invasive, or affecting the integrity of the skin and oral cavity. For VOC monitoring, these sensing devices can be Electronic-nose (E-nose) technology or Gas Chromatography (GC). Therefore, this program is called SCENT, which stands for Screening for COVID-19 by Electronic-Nose Technology. This FOA seeks to advance novel biosensing technologies that are innovative, safe, and effective using integrated artificial intelligent, pattern recognition and machine learning systems that would make it possible for the detection, diagnosis, prediction, and monitoring of COVID-19 in clinical, community and everyday settings.
• This FOA requires multidisciplinary collaborations to ensure project success. Disciplines may include: biomedical engineers, material scientists, biosensing experts, software engineers, chemists, dentists, clinicians, virologists, clinical trialists, biostatisticians, data analysts and/or other relevant experts in academia and industry. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kids) (R61/R33 Clinical Trial Optional) RFA-OD-20-023

Applications due September 30, 2020

• The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• This FOA seeks to support innovative research to develop novel, new or unique and non-traditional approaches (e.g. diagnostic and prognostic biomarkers and/or biosignatures) to identify and characterize the spectrum of SARS CoV-2 associated illness, including the multisystem inflammatory syndrome in children (MIS-C) and, through a prognostic algorithm, predict the longitudinal risk of disease severity after a child is exposed to and may be infected with SARS-CoV-2 to properly tailor his or her management and optimize health outcomes.
• The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)

LOI due date is 8/30/2020; Applications due 9/30/2020.

• NIH is issuing this Funding Opportunity Announcement (FOA) in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
• This FOA invites applications to pursue development and validation studies of COVID-19 surveillance methods, not based or focused on direct viral testing of individuals, in settings and institutions, including residential, with a high density of individuals who are together for prolonged periods of time. There are numerous promising technologies which could allow for multimodal surveillance inputs. However, these technologies are often not interoperable, not optimized for integration to increase robustness and not tested for general applicability to public health or for the specific need of high-risk population surveillance. Applications are invited that translate a combination of digital surveillance modalities into platforms that can assist the professional staff of high-risk facilities in making clinically meaningful care recommendations for patients at risk of COVID-19 or other respiratory viruses. Projects proposed may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate.
• The funding for this initiative is provided form the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) RFA-OD-20-019

Applications due 9/30/2020; LOI due 8/31/2020

• NIH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative. Specifically, this FOA seeks to fund a single cooperative agreement for a Data Coordination Center (DCC) to serve as a communication center and data hub for RADx-rad awardees. The funding for this award is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

NIH Director’s Emergency Transformative Research Awards (RFA-RM-20-020)

Applications due 9/30/20

• Transformative Research Awards from CARES Act funding that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics

Notice of Special Interest: Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities(NOT-ES-21-002)
Expiration date is December 30, 2020

• The purpose of this supplement is to provide support for successful applicants to develop partnerships with local worker centers and community organizations specifically targeting under served and disadvantaged communities with higher than average COVID-19 transmission rates.
• Components of a COVID-19 Recovery Centers for essential workers should include all of the following highly recommended components. Additionally, the optional components may be added on but are not required.
• Highly Recommended Components:
  • Local health and safety education and training delivery (classroom and online) using effective infection control plans and adult learning methods to include literacy and English as a second language, population education techniques, as well as multi-lingual training to increase the education and awareness of COVID-19 health risks and protective measures
  • Partnership between a WTP grantee and at least one local community organization that supports outreach to one or more populations vulnerable to COVID-19
  • Integration of existing NIEHS WTP tools, resources, and curricula into training
  • Available sourcing and distribution point of needed personal protective equipment (masks, respirators, face shields, etc.)
  • Coordination with local disaster preparedness, response, and recovery resources to assist vulnerable communities in connecting with the emergency response and recovery process
  • Assessment of program impact and effectiveness to help evaluate how local partnerships with essential workers organizations can help with COVID-19 community recovery
  • IT Technical Assistance and best practices and data integration with virtual learning
  • Appropriate partnership for the proposed project, such as with local public health agencies and area employers, to facilitate connectedness to resources such as testing, contact tracing, and the adoption of effective infection control measures.

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool (NOT-OD-20-152)
Due date is September 1, 2020

• NIH is issuing this NOSI in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This emergency NOSI from the National Institutes of Health (NIH) provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative. The goal of the RADx-rad initiative is to encourage the development of novel, non-traditional approaches to identify the current SARS-CoV-2 virus or other markers of the COVID-19 disease that can be used in future outbreaks of COVID-19 and that could be applicable to other, as yet unknown, viruses. Specifically, the goal of this NOSI is to solicit proposals to enhance the utility of chemosensory testing as a COVID-19 screening tool by using objective tests to examine the onset and prognostic value of chemosensory loss and to encourage the development and/or deployment of home-based and on-site chemosensory tests. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR (NOT-DE-20-022)
Application due date: November 2, 2020

• NIDCR will place a high priority on topics that would be of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices.  New knowledge about SARS-CoV-2 transmissibility, stability on surfaces, viral particle size, and presence in saliva have catalyzed a need to consider how the practice of dentistry will be performed in the near and long-term future.

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials (NOT-HL-20-782)
Expires 10/6/20

• NHLBI seeks to leverage existing clinical trials expertise and, using NHLBI programs that are actively conducting Phase I-III clinical trials, to rapidly initiate and conduct Phase I-Phase I/II (bridging) clinical trials in patients at risk for SARS-CoV-2 infection and/or patients with COVID-19. It is strongly recommended that the parent activity code be one of the following: P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, or UM1.

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-011)
Applications accepted on a rolling basis through 10/6/20

• NCCIH, NIA, and NIAAA are accepting applications for supplements and revisions to active projects. Topics of specific interest for this NOSI include research on stress management strategies, including mind and body approaches,that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-008)
Applications accepted on a rolling basis through 11/10/20

• The NIBIB is seeking applications from current grantees to develop life-saving technologies that can be ready for commercialization within one to two years.

Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need
Applications will be accepted immediately and on a rolling basis through November 10, 2020

• Encouraging supplement proposals to support the NCATS National COVID Cohort Collaborative (N3C): Provision of clinical data in specified formats to support illness/infection status/surveillance determinations and/or clinical study data (awards anticipated to be $50,000 to $100,000 Total Costs)

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
Applications will be accepted immediately and on a rolling basis through November 10, 2020

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
Applications will be accepted on a rolling basis from June 10, 2020 through December 15, 2020. Applications submitted before July 15, 2020 will be considered for funding in in Fiscal Year 2020

• The purpose of this NOSI is to support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact. Administrative supplements and competitive revisions applications are expected to describe how research outcomes will lead to a tangible difference within 6 months to a year of completing the supplement work, with respect to improving how we identify, treat, or provide services for health conditions secondary to the COVID-19 pandemic for health disparate and vulnerable populations. 

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
Applications are due: 12/1/20

• Encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups

RFA-AA-20-009 — Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional) 
Applications are due 11/17/20

• The Funding Opportunity Announcement will solicit applications for human studies that will advance operations or implementation research in the context of alcohol and HIV/AIDS by facilitating the development of: (1) broader systems approaches for monitoring complex HIV and alcohol-related morbidity and mortality, and (2) interventions to reduce the impact of alcohol on HIV disease progression and transmission.  

Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21)(NOT-LM-20-011)
National Library of Medicine

• NLM is accepted new R21 applications on the June 16, 2020 deadline only. NLM is encouraging the submission of R21 applications to address the following research areas of interest: (1) Methods for mining clinical data that can be used to identify or predict presence of COVID-19 in biomedical phenotype data, or other relevant topics such as discovery of risks for infection by SARS-Cov-2 viruses, use of standard terminologies for these viruses in federated health data sets; (2) Public health surveillance methods that mines genomic, viromic, health data, environmental data and/or data from other pertinent sources such as social media, to identify spread and impact of SARS-Cov-2

NCATS Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (NOT-TR-20-012)
Application due dates vary by mechanism (Notice expires on 10/17/20)

• National Center for Advancing Translational Sciences (NCATS) is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.  Grant mechanisms include Bench Testing (UG3/UH3), Clinical Trial Planning (U34), or Clinic Testing (U01).

NIGMS Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025)
Applications will be accepted on a rolling basis until 2/5/21

• NIGMS will accept the submission of applications to address incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive models for the spread of SARS-CoV-2 and other related infectious agents (all relevant grants), repurpose/modify diagnostics tools for rapid detection (SBIR/STTR only) and development of therapeutics (SBIR/STTR only).  Applications must be submitted to PA-18-935 which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.

Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use NOT-AA-21-001 (R01); NOT-AA-21-002 (R03); NOT-AA-21-003 (R21)

• The National Institute on Alcohol Abuse and Alcoholism intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for addressing urgent, time-sensitive research questions on the relationships between alcohol consumption/misuse and COVID-19 related outcomes and consequences. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in late winter 2021 with an expected application due date in Spring 2022.
• Priority research areas include, but are not necessarily limited to:
  • Conduct secondary analyses of COVID-19- and alcohol-related datasets.
  • Determine the influence of alcohol consumption on susceptibility to SARS-CoV-2 infection and COVID-19 outcomes, including post-acute sequelae.
  • Determine how alcohol misuse and alcohol use disorder (AUD) may contribute to neurological and psychiatric manifestations of COVID-19.
  • Characterize changes in alcohol consumption during the pandemic and investigate the pandemic-related causes.
  • Identify best practices in service delivery and barriers to service delivery during the pandemic.

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional, RFA-DK-20-021)
Applications are due 12/16/20

• This FOA support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. 

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional)
Applications are due 12/2/20, or 3/2/21

• Focuses on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
Applications are due: 11/2/2020, 11/2/,2020, 12/1/2020, 1/4/2021, 2/1/2021

• Invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19)

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
Applications are due November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021.

• This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19). 

New COVID-19 priority areas and due dates for PAR-19-373 and PAR-19-384, “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)”
Next application due date: 3/17/21

• These FOAs solicits research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. There are new priority topics related to COVID-19 pandemic.

Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II) NOT-OD-21-064 (Release Date: March 22, 2021; Estimated Publication of Funding Opportunity Announcement: April 1, 2021)

The National Institutes of Health (NIH) is issuing this Notice to alert the community about four upcoming Funding Opportunity Announcements (FOAs) as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative to solicit intervention research on COVID-19 diagnostic testing among underserved and vulnerable populations. The FOAs are expected to be published in April, and NIH acceptance of applications will depend on the time frame outlined in each opportunity announcement, but will be no later than July 31. The FOAs will include two Requests for Applications (RFAs) and two Notices of Special Interest (NOSIs). The goal is to make awards as early as October 2021.

Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations (NOT-NS-21-037)

First Available Due Date is May 5, 2021; Expiration Date is May 6, 2021.

• NINDS is interested in applications for supplements to human subjects awards administered by the NINDS to conduct research on the effects of COVID-19 on the development of, or disease progression in, Alzheimer’s Disease-Related Dementias (ADRDs). ADRDs include Frontotemporal Degeneration (FTD), Lewy Body Dementia (LBD), Vascular contributions to Cognitive Impairment and Dementia (VCID), and Mixed Etiology Dementias (MED). Older adults are known to be especially vulnerable to COVID-19 infection, and COVID-19 infection commonly presents with neurological signs and symptoms. The effect of COVID-19 exposure on subjects who have, or are at risk for developing ADRDs is unclear. Investigators who are currently researching ADRD or at-risk for ADRD populations are encouraged to apply for additional support to examine the impact of COVID-19 in these subjects. Research topics of interest may include (but are not limited to):
  • The effect of symptomatic or asymptomatic COVID-19 infection on progression to cognitive impairment or dementia in populations that are at risk for ADRDs.
  • The effect of symptomatic or asymptomatic COVID-19 infection on progression of dementia in patients with existing ADRDs.
  • COVID-19 induced hyposmia/dysgeusia as a risk factor(s) for progression to dementia in at-risk for ADRD populations, or progression of dementia in people with ADRD diagnoses..
  • Evidence of new or worsening ADRD-related neurophysiology (e.g., small vessel disease, ischemia, or atrophy on MRI, alterations in blood or CSF proteins, etc.) that occur after symptomatic or asymptomatic COVID-19 infection.
• Studies proposed in the supplement application must be within scope of the original parent application’s research. Applicants may request funds to cover the costs of additional subject enrollment, personnel, or assessments (e.g., COVID-19 testing, cognitive assessments, smell testing, neuroimaging).

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement – Clinical Trial Optional) (NOT-OD-21-103)

First Available Due Date: May 24, 2021; Expiration Date: May 25, 2021.

• The National Institutes of Health (NIH) are issuing this NOSI in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This NOSI provides an expedited funding mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for RADxSM-UP is provided from the American Rescue Plan Act of 2021.
• The NIH Office of the Director (OD) is issuing this NOSI to request competitive revision applications addressing the objectives described below. This NOSI is one of four related RADxSM-UP funding opportunities. This Testing Research Projects NOSI will support research teams with established community-engaged partnerships to address the scientific objectives described herein.

Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19 (NOT-OD-21-071)

First Available Due Date is April 14, 2021; Expiration Date is April 21, 2021.

• The Office of the Director of the National Institutes of Health (NIH), on behalf of the NIH Maternal Mortality Task Force, announces the opportunity for investigators with relevant active NIH-supported grants to address the following scientific priorities for Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) in the context of the ongoing COVID-19 pandemic for pregnant persons and up to one year postpartum:
  • Understand the effects of SARS-CoV-2 infection and the COVID-19 pandemic on maternal mental health, well-being, functioning and quality of life
  • Identify psychosocial and behavioral health risk factors related to the COVID-19 pandemic that affect maternal mental health and functioning outcomes
  • Address the impact of structural racism and discrimination (SRD) on maternal health outcomes in the context of COVID-19
• NIH is soliciting the submission of applications for Administrative Supplements or Urgent Competitive Revisions to active awards that include or could extend to pregnancy and COVID-19. Applications in response to this NOSI should be aligned with one or more of the areas of interest below. Example research questions are provided for each area of interest (see announcement for the example research questions are the areas listed below):
  • Area 1: Investigate the impact of the COVID-19 pandemic on the health, well-being, and functioning of pregnant persons and up to one year postpartum using psychosocial and behavioral research approaches.
  • Area 2: Investigate the impact of SRD in the context of the COVID-19 pandemic on the health and well-being of persons during pregnancy and up to one year postpartum.
  • Area 3: Understand how knowledge, attitudes, and beliefs about COVID-19 influence decisions and behaviors related to COVID-19 testing and vaccination during pregnancy and up to one year postpartum.
  • Area 4: Develop an integrated understanding of pregnancy-related and pregnancy-associated morbidity and MM causes, related to COVID-19.

Notice of Special Interest: Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control (NOT-CA-21-033)

Expiration Date: April 1, 2021

• This Notice of Special Interest (NOSI) informs current awardees that the National Cancer Institute (NCI) is providing the opportunity for supplemental funding to stimulate interest and promote studies on the impact of the COVID-19 pandemic on global cancer prevention and control. This Administrative Supplement is designed to support NCI-funded investigators who have existing relationships/partnerships in low- and middle-income countries (LMICs), inclusive of upper-middle-income countries, to leverage those partnerships to conduct research on the pandemic’s impact on cancer prevention, diagnosis, treatment, and outcomes.
• Studies should contribute to understanding the impact of COVID-19 on global cancer prevention and control. This may include the direct effects of COVID-19 in cancer patients or the indirect health, economic, and sociocultural impacts of the pandemic across the cancer continuum.
• Studies that generate an evidence base necessary to mitigate the effects of this and future pandemics on persons with cancer, at risk for cancer, undergoing treatment for cancer, or in remission are especially encouraged.

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
(NOT-NS-20-051)
Expires 4/15/21

• NINDS is encouraging the submission of competitive revision or administrative supplement applications for supplements to address the biology, pathophysiology, prevention, diagnosis, sequelae, or treatment of the 2019 Novel Coronavirus that are directly related to the NINDS mission.

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (NOT-OD-20-097)
Applications will be accepted on a rolling basis through 3/31/21

• OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI, and ORWH encourage submission of applications for urgent competitive revisions or administrative supplements to active grants studying existing longitudinal cohorts, particularly those cohorts with considerable data relevant to COVID-19 social and behavioral factors prior and subsequent to the SAR-CoV-2 outbreak in various locations. Submissions are encouraged to consider four areas: public health mitigation efforts; economic, social and personnel well-being; misinformation being communicated; downstream health effects from economic and social impacts.

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus (NOT-MH-20-047)
Applications accepted on a rolling basis until 4/15/21

• NIMH, NIA, NIAAA, and NIMHD are accepting applications for supplements and revisions to active projects that significantly improve our understanding of the risks, mechanisms, and treatment in response to COVID-19 among individuals at risk for, or experiencing mental disorders across the full lifespan. This includes but is not limited to, individuals with Mild Cognitive Impairment (MCI), Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD) and their healthcare providers and caregivers.

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities (NOT-MD-20-019)
Applications accepted on a rolling basis until 5/1/21

• NIMH, NIA, and NIMHD are accepting applications for supplements and revisions to active projects. This NOSI is soliciting research in health disparity populations that -seeks to understand: 1) how state and local policies and initiatives mitigate or exacerbate disparities in health services use and health outcomes; 2) the role that community-level protective and resilience factors and interventions have in mitigating the effects of the sector disruptions that the COVID-19 outbreak causes; and 3) how behavioral and/or biological mechanisms may contribute to COVID-19 manifestations.

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-015 / PA-20-135)
Applications are accepted the first week of each month. See Notice for specific dates. (Notice expires on 5/4/21)

• NIEHS is particularly interested in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. NIEHS is accepting applications addressing COVID-19 through the urgent competitive revision, and time-sensitive mechanisms (see Application Information below).

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-AG-20-022)
Applications will be accepted on a rolling basis from April 6, 2020 through May 1, 2021

• In order to rapidly improve our understanding and available control measures for 2019-nCoV, NIA is encouraging the submission of applications for either Administrative Supplements (PA-18-591) or Competitive Revisions (PA-18-935) to active grants to address multiple areas of interest within the mission of NIA.

NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047)
Applications will be accepted on a rolling basis through 3/31/21

• NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Applications must be submitted using the following funding opportunities: PA-18-935, which is intended to provide funds for NIH grantees applying to expand the scope of their active grant, or PA-18-591, which is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant.

NIAID Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-031)
Application due dates depend on grant mechanism (Notice expires on 4/5/21)

• National Institute of Allergy and Infectious Diseases (NIAID) is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. Applications may be submitted as administrative supplements (PA-18-591) to existing awards.

Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (NOT-OD-21-097)

Release date: March 29, 2021 (Letters of interest will be due by April 16, 2021)

• The purpose of this Notice is to alert the community that NIH plans to publish a Research Opportunity (RO) as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADxSM-UP) initiative to solicit research on COVID-19 diagnostic testing approaches to safely return children and staff to the in-person school setting in underserved and vulnerable communities (NOT-OD-21-065).
• This open solicitation will be an opportunity to start new cohorts or approaches to gain data related to safe return to the in-person learning environment. A letter of interest will be required to be considered for the opportunity to participate in the Research Opportunity. Guidance on the development and submission of the letter of interest is available at the following web address: https://grants.nih.gov/sites/default/files/RADx-UP-LOI.pdf.The letters of interest will be reviewed by NIH staff and specific programs will be invited to submit and compete with full proposals. The letters of interest will be due by April 16, 2021, 5 PM local time of the applicant organization.

SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 RFA-AA-21-003) (R01 RFA-AA-21-002) (R21 RFA-AA-21-004)

Expiration Date is April 15, 2021.

• R03 This Funding Opportunity Announcement (FOA) will support research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences. The principal area of focus is research that can improve public health in the near term by informing responses to the current COVID-19 pandemic, in view of 1) the impact of alcohol misuse on incidence and severity of COVID-19 disease or 2) the effect of the COVID-19 disease and pandemic-induced restrictions on alcohol use and alcohol use disorder (AUD). Time-sensitive applications for which standard NIH review and funding timelines would compromise either the ability to conduct the research or the value of the knowledge and with the potential to inform responses to the current pandemic will be considered. This FOA uses the R03 mechanism, which is intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.
• R01 This Funding Opportunity Announcement (FOA) will support research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences. The principal area of focus is research that can improve public health in the near term by informing responses to the current COVID-19 pandemic, in view of 1) the impact of alcohol misuse on incidence and severity of COVID-19 disease or 2) the effect of the COVID-19 disease and pandemic-induced restrictions on alcohol use and alcohol use disorder (AUD). Time-sensitive applications for which standard NIH review and funding timelines would compromise either the ability to conduct the research or the value of the knowledge and with the potential to inform responses to the current pandemic will be considered. Applications to this RFA should be accomplished within a three year project duration.
• R21 This Funding Opportunity Announcement (FOA) will support research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences. The principal area of focus is research that can improve public health in the near term by informing responses to the current COVID-19 pandemic, in view of 1) the impact of alcohol misuse on incidence and severity of COVID-19 disease or 2) the effect of the COVID-19 disease and pandemic-induced restrictions on alcohol use and alcohol use disorder (AUD). Time-sensitive applications for which standard NIH review and funding timelines would compromise either the ability to conduct the research or the value of the knowledge and with the potential to inform responses to the current pandemic will be considered. This FOA uses the R21 grant mechanism, which is intended to support investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research.

Notice of Special Interest: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (NOT-TR-21-006)

Expiration Date is March 17, 2021; First Available Due Date is October 30, 2020

• National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.
• The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include the following:
  • Testing a publicly posted therapeutic candidate for use to treat COVID-19. Examples include clinical candidate therapeutics in documents publicly posted by the World Health Organization (types/classes of candidate therapeutics) and (candidates for clinical evaluation).
  • Testing a candidate therapy to treat COVID-19 that was already identified with a publicly available computational approach.
  • Testing of existing therapeutic candidates that work on mechanistic targets shared among other viruses that may be relevant to SARS-CoV-2.

• NCATS is soliciting applications to PAR-17-465, PAR-18-462, and PAR-18-332.

Notice of Special Interest (NOSI): Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations (NOT-MD-20-026)
First Available Due date 10/5/20; Notice expires on 5/8/21

• The purpose of this Notice of Special Interest is to support multidisciplinary, investigative and collaborative research focused on developing and testing multi-level strategies to effectively implement recommended guidelines of comprehensive clinical care for individuals with Type 2 diabetes from health disparity populations.
  • One example of potential topic areas mentions COVID-19
    • Studies on the multi-level effects of the COVID-19 pandemic and/or their intersection on access to health care services and continuity of care, for example patient level factors (e.g., loss of health insurance due to job loss; impact on self-management due to caregiving and homeschooling responsibilities) health care setting level factors (e.g., changes and rescheduling of services due to policies on physical distancing; medication availability and refills, health care settings strategies and best practices to ensure appropriate and timely care), and societal factors (impact of policies on physical distancing on nutrition, physical activity, and emotional well-being). Costs/economic analyses are of interest.

Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01)
Applications will be accepted on a rolling basis, beginning on 8/6/2020; expires January 24, 2021.

• The purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The therapeutic agent must have already completed at least a Phase I clinical trial for a different indication, and not require additional regulatory studies for the new indication prior to starting a clinical trial.

RadX – Tech – NIH POCTRN Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing
Accepting proposals for support on a rolling basis until further notice

• NIBIB is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities.

Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) (RFA-ES-19-011 / NOT-ES-20-015)
Applications are accepted the first week of each month. See Notice for specific dates. (Notice expires on 5/4/21)

• NIEHS is particularly interested in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. NIEHS is accepting applications addressing COVID-19 through the urgent competitive revision, and time-sensitive mechanisms (see Application Information below).

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-007)
Application standard due dates apply (Notice expires on 3/31/21)

• The NIBIB is seeking new R01, R21, and R03 applications to develop life-saving technologies that can be ready for commercialization within one to two years.

Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-006)
Standard application due dates apply (Notice expires on 3/31/21)

NIAID Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-031)
Application due dates depend on grant mechanism (Notice expires on 4/5/21)

• National Institute of Allergy and Infectious Diseases (NIAID) is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. Applications may be submitted through R03, R21, or R01 mechanisms.

Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19 (NOT-HL-21-009)

Release date (3/16/2021); Applications due dates: 04/15/2021; 05/17/2021; 06/25/2021.

• NIH recently released NOT-OD-21-052 which provided general guidance for early career scientists affected by COVID-19 to request no-cost extensions or funded extensions. This NHLBI Notice provides additional guidance for currently-funded NHLBI K01, K08, K23, and K25 recipients impacted by COVID-19 seeking funded extensions.

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) (PAR-20-256)

Applications accepted on a rolling basis, expires July 8, 2021.

• The purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by “The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020” and “The Coronavirus Aid, Relief and Economic Security (CARES) Act”.
• Applications accepted on a rolling basis.
• NIAID intends to commit up to $25M for this initiative. Application budgets are not limited but need to reflect the actual needs of the proposed project.

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-059)
Notice expires on 7/2/21

• NIAID is allowing the submission of applications for Competitive Revisions to active grants to increase and enhance select research efforts to facilitate the Federal SARS-CoV-2/COVID-19 research response. Areas of interest are limited to:
  • Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response, e.g., equipment sharing arrangements. Applications proposing new construction, alterations and renovations for planned and active BSL3 facilities are not responsive to this NOSI;
  • Generation of critical reagents to support the SARS-CoV-2/COVID-19 research response;
  • Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; and
  • Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities. Applications proposing clinical trials are not responsive to this NOSI.

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
Application Due Dates are 11/12/20, 3/12/21, or 7/12/21

• This NOSI highlights the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in individuals with Down syndrome in conjunction with the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project. The overarching goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population, which may be disproportionately affected by, have higher infection rates of, and/or be at elevated risk for adverse outcomes from contracting the virus.

Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-AG-21-035)

Application due date is June 9, 2021.

• The purpose of this Cooperative Resource-Related Research Project FOA is to establish a coordinating center to support and develop research, dissemination, and various data sharing activities for social, behavioral, and economic research on COVID-19. The Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (SBECCC) will foster innovation, collaboration, and synergies across researchers funded through the Social, Behavioral and Economic Research on COVID-19 Consortium (U01) program and other relevant NIH-funded studies by supporting networking activities intended to advance research in the field; supporting the development and use of harmonized COVID-19 data constructs for primary and secondary data to support comparability and replicability; assisting in efficient and enhanced sharing/discoverability of data; and disseminating findings to the research community and the public.

Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional) (RFA-OD-21-008)

Application due date: July 7, 2021

• The National Institutes of Health (NIH) are issuing this funding FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This FOA provides an expedited funding mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for this program is provided from the American Rescue Plan Act of 2021.

Emergency Award: RADx-UP – Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) (RFA-OD-21-009)

Application due date: July 7, 2021

• This funding opportunity announcement (FOA) uses an emergency U01 mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for this initiative is provided from the American Rescue Plan Act of 2021 .

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-21-019)

First Available Due Date: March 15, 2021; Expiration Date: December 16, 2021

• There is an urgent public health need to better understand SARS-CoV-2, particularly to improve the predictive quality of existing models of spread, diagnostics for measurement of transmission, susceptibility and recovery, efficacy and economic impact of mitigations and vaccination strategies, and differences in transmission and natural history among different SARS-CoV-2 variant strains.
• NIGMS will accept the submission of applications for Competitive Revisions to all active NIGMS grants to address only the following research area:
  • Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive computational models for the spread of SARS-CoV-2 and other related infectious agents. Efforts may include, for example, models for vaccination or other mitigation strategies, potential economic impacts and other topics related to transmission of SARS-CoV-2 variants.

Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have been Significantly Impacted by COVID-19 (NOT-OD-21-052)

Release Date: February 2, 2021

• The COVID-19 pandemic, along with extensive mitigation measures, has adversely affected progress in many biomedical research settings. Evidence from multiple sources, including a survey NIH issued to its extramural research workforce, indicates legitimate concerns about career trajectory for early career scientists. Therefore, within existing constraints of available funding, NIH plans to support early career scientists whose career trajectories have been significantly affected by the pandemic.
• Therefore, NIH is providing an opportunity for recipients of NIH Fellowship (“F”) and NIH Career Development (“K”) awards who have been impacted by COVID-19 to request extensions as follows:
• No-Cost Extensions For most NIH awards, recipients may extend the final budget period of the previously approved project period (e.g. no-cost extension) one time, without NIH prior approval. For Fellowships and some career development awards (e.g., K99), the first no-cost extension may be submitted by the Authorized Organization Official (AOR) as a prior approval request to the funding IC(s). Recipients may also submit prior approval requests for second no-cost extensions. These requests must include a justification outlining the impact of COVID-19 on the recipient’s training and career development activities and will be considered by the funding IC(s) on a case by case basis.

Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium  (PAR-21-213)

Letter of Intent due dates: May 9, 2021; October 8, 2021; Expiration Date is November 9, 2021

• The purpose of this FOA is to advance research on the impact of COVID-19 and associated mitigation efforts on individual, family, and community behavior, as well as research on how subsequent economic disruption affects health-related outcomes. Emphasis should be placed on addressing these questions in underserved and vulnerable populations (see Definitions above). Health effects/outcomes studied are not limited to direct effects of infection and can/should consider indirect and secondary effects of the pandemic. Priority research questions include but are not limited to the following:
• Behavioral and social factors contributing to SARS-CoV-2 transmission and prevention, such as individual, family, community, and environmental influences that shape adherence to and transmission reduction from coronavirus mitigation behaviors including COVID-19 vaccination.
• The integration of economic feedback to mitigation policies and behaviors affecting estimates of transmission/prevention. The impact of timing and design of state and local government mitigation policies on differentially affected transmission.
• How communication disorders or use of hearing aids, American Sign Language, or associative and augmentative communication (AAC) devices impact the likelihood of contracting the SARS-COVID-2, suffering adverse effects from infections, or management of mitigation protocols.
• Leveraging and integrating data from large cohort studies for the development of machine learning algorithms and other novel methods for prediction models of COVID-19 transmission as well as impact of interventions on transmission.
• The impact of public health interventions to mitigate COVID-19 transmission on preventive care delivery and use (e.g., mental health care, drug/alcohol use treatment, well-visits, vaccinations, other routine preventive care) and the quantified effects on health.
• The impact of the pandemic and the concomitant public health response on the management of chronic conditions and disabilities (e.g., cardiovascular disease, HIV, autism, individuals with spinal cord injuries), including effects on self-management of illnesses and relevant health behaviors (e.g., diet, sleep, physical activity, medication adherence, health-monitoring).
• How the pandemic and associated mitigation policies have affected care of patients with in-person care needs (e.g., persons with dementia) and their caregivers.
• The impact of the pandemic and concomitant public health response on the management of pregnancy and the post-partum period, including access to healthcare, self-management of health behaviors, and the impact on maternal mortality and morbidity, and pregnancy outcomes, including the management and development of pre-term and other medically fragile infants.
• How school closures and alternative educational approaches in response to the coronavirus pandemic have affected child development and learning in the short- and long-term, including among children with physical and psychological disabilities; and how school closures have impacted parental functioning and behavioral health (e.g., stress, substance use, etc.).
• Shifts in modes of healthcare (e.g., telemedicine) and how these shifts are impacting health outcomes.
• Access to telehealth as a function of health disparities and vulnerability, and the impact of differential access on mental health and substance use-related concerns.
• The underlying mechanisms linking the pandemic and mitigation strategies with mental and behavioral disorders.
• The effect of public health mitigation efforts on family- and community-level outcomes, including but not limited to the prevalence of interpersonal violence in families; changes in prevalence of poverty at the community/county/state level; behavioral health symptoms including but not limited to depression, anxiety, and substance use; and the interaction between these various phenomena.
• The consequences on individual and community health of policies and programs whose primary intention may not have been to address health outcomes (e.g., economic stimulus).
• Assessment of differential death rates because of COVID that consider biological and social determinants of health.
• The efficacy of communication to vulnerable populations about preventative health measures (e.g., hand washing, mask wearing, physical distancing, testing, vaccines) and associated adherence outcomes: what modes of communication are most effective and why?
• Relevant approaches may include but are not limited to:
  • Development of computational, statistical, and mathematical models for the spread and outcomes of COVID-19 and results of possible interventions, including incorporation of economic models related to health and well-being.
  • “Natural experiments” making use of time and place differences in policies, programs, economic circumstances, and other exogenous factors to identify causal factors.
  • Linking of large datasets and nationally representative surveys to assess mortality, comorbidity, and healthcare utilization differentials across sex/gender, racial/ethnic, urban/rural, and socioeconomic lines.
  • Development of statistical models to predict immediate, mid-, and long-term health and economic outcomes across individuals’ lifespan.
  • Leveraging of new data sources (e.g., sensors), data integration (especially at multiple levels of influence), and artificial intelligence and computational modeling.

Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE)(R01) (RFA-AI-21-023)

Application Due Date: July 30, 2021

• The purpose of this FOA is to build upon knowledge of HIV in the U.S. and to use this knowledge to create more effective, more timely, and tailored approaches to end the HIV epidemic. Research funded under this FOA will rapidly identify priority populations and where HIV is spreading and provide data-driven evidence-based guidance for public health decision-making to support the goals of the Ending the HIV Epidemic: A Plan for America (EHE) initiative through the RESPOND pillar.
• Health systems need to adapt to more rapidly detect transmissions, identify outbreaks, and guide tailored decision-making, particularly as the epidemiology of HIV changes due to successful public health interventions or unanticipated care disruptions such as the COVID-19 pandemic. EHE demands innovative research to understand, as close to real time as possible community, structural, and population influences on HIV transmission. Respond: EEE provides an opportunity to scale-up and focus research in highly affected communities and in persons of highest need of HIV prevention, care and treatment.
• The HIV epidemic is expected to change as the EHE initiative is successful in reducing HIV transmissions. To continue to be successful, the EHE community will need robust data to identify and communicate with stakeholders about potential changes in vulnerable populations and to implement the most appropriate and effective interventions. Along with contributing directly to EHE-specific activities, projects funded through this FOA could help to identify hidden, obscure, and/or previously unrecognized factors that contribute to HIV transmission in communities. Accurate epidemiology that is focused on the needs of implementing partners is key to the development of more timely knowledge that will better inform interventions to improve response, link those in need to appropriate care, and slow transmission.

Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases (NOT-AR-21-012)

Expiration date is November 19, 2021

• The outbreak of COVID-19 caused by the novel SARS-CoV-2 has spread worldwide leading to large numbers of infections and deaths. A wide spectrum of clinical manifestations and outcomes, ranging from asymptomatic disease to multiorgan failure, has become a hallmark of the COVID-19 pandemic. Patients with many underlying diseases and conditions are at increased risk of acquiring and having adverse outcomes from SARS-CoV-2 infection. Furthermore, persistent symptoms (post-acute sequelae), including fatigue, muscle pain, weakness or wasting, joint pain, skin rash, arthritis, and biobehavioral changes, are being reported among COVID-19 survivors, even among individuals who initially experience a mild acute illness. As of this writing, the FDA has issued Emergency Use Authorization for two vaccines recommended to prevent COVID-19, and several other vaccines and treatments are in various stages of preclinical and clinical development. While there is no obvious indication of adverse events or impacts of the use of these vaccines in individuals with underlying rheumatic, skin, and or musculoskeletal diseases/conditions, research studies should be carried out to determine if these individuals will be affected differently by COVID-19 vaccines and treatments as compared to those without such conditions. In line with overall NIH efforts, NIAMS would like to promote basic, translational, pre-clinical and clinical observational research focused on COVID-19 infection and its intersection with rheumatic, musculoskeletal, and skin diseases and conditions.
• This NOSI encourages, but is not limited to, research applications focused on:
• Susceptibility to, prevalence, risk assessment, and clinical management of COVID-19 among patients with underlying rheumatic, musculoskeletal, and/or skin diseases;
• The impacts of drugs or other targeted therapies that are used to treat diseases within the mission of NIAMS on susceptibility, severity, and management of COVID-19;
• Health disparities and social/behavioral factors that contribute to risk of infection, organ injury and adverse outcomes in COVID-19 patients with underlying rheumatic, musculoskeletal, and/or skin diseases;
• Impact of COVID-19 vaccination of patients with underlying rheumatic, musculoskeletal, and/or skin diseases;
• Characterization of long-term post-acute sequelae occurring in recovered COVID-19 patients with co-existing rheumatic, musculoskeletal, and/or skin diseases;
• Characterization of NIAMS-mission related long-term post-acute sequelae (e.g. muscle pain, joint pain, biobehavioral changes, skin rash, arthritis, etc.) occurring in recovered COVID-19 patients.

Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
Expiration date is 9/1/2021; First Available due date is 9/01/2020

• This Notice of Special Interest encourages cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials, as defined by NIAID in PAR-18-633 and NOT-AI-16-084, that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate:
  • SARS-CoV-2 candidate vaccines
  • non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19
  • therapeutic approaches to treat COVID-19
• Please note, studies evaluating behavioral interventions (e.g., impact of face masks, hand- washing, social distancing) and those focused on disinfecting surfaces and equipment are not responsive and will not be considered for this NOSI initiative.
• Investigators interested in responding to this NOSI are strongly encouraged to submit a written request for prior consultation to the email address listed below prior to submission of an NIAID Clinical Trial Implementation (U01) Cooperative Agreement application in response to PAR-18-633 to discuss the proposed project in the context of the needs identified above. This request should be as succinct as possible and include the study title and a brief description of the study and product to be evaluated; study PI; primary institution and potential collaborating sites; industry partners, if applicable; and a cost estimate. As a reminder, per NIH policy, applicants requesting $500,000 or more in direct costs in any year (excluding consortium F&A) must contact NIAID staff listed below no later than 6 weeks before submission and follow the Policy on the Acceptance for Review of Unsolicited Applications that Request $500,000 or More in Direct Costs as described in the SF424 (R&R) Application Guide.

Notice of Intent to Publish a Funding Opportunity Announcement for HEALthy Brain and Child Development Study (NOT-DA-20-069)

• NIH plans to publish a set of Funding Opportunity Announcements (FOAs) as part of the Helping to End Addiction Long-term^SM (HEAL) Initiative to support research project sites, a Data Coordinating Center, and a Consortium Administrative Core for the HEALthy Brain and Child Development (HBCD) Study. The primary objective of the HBCD Project is to conduct a large scale multi-site longitudinal study that can prospectively examine human brain, cognitive, behavioral, social, and emotional development beginning at birth and extending through middle childhood. The FOAs are expected to be published in Fall 2020 with an expected application due date in WINTER 2021.

NSF Opportunities

NSF Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) (NSF 20-055)
Applications may be submitted anytime

• The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.

NSF Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19  (Funding Opportunity Number: NSF 20-065)
There are four submission windows for Phase I proposals in 2020.

• The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis

Smart and Connected Communities (S&CC) (NSF 21-535)
Full Proposal Deadline is February 24, 2021

• Communities in the United States (US) and around the world are entering a new era of transformation in which residents and their surrounding environments are increasingly connected through rapidly-changing intelligent technologies. This transformation offers great promise for improved wellbeing and prosperity but poses significant challenges at the complex intersection of technology and society. The goal of the NSF Smart and Connected Communities (S&CC) program solicitation is to accelerate the creation of the scientific and engineering foundations that will enable smart and connected communities to bring about new levels of economic opportunity and growth, safety and security, health and wellness, accessibility and inclusivity, and overall quality of life.
• For the purposes of this solicitation, communities are defined as having geographically-delineated boundaries—such as towns, cities, counties, neighborhoods, community districts, rural areas, and tribal regions—consisting of various populations, with the structure and ability to engage in meaningful ways with proposed research activities. A “smart and connected community” is, in turn, defined as a community that synergistically integrates intelligent technologies with the natural and built environments, including infrastructure, to improve the social, economic, and environmental well-being of those who live, work, learn, or travel within it.
• S&CC Integrative Research Grants (SCC-IRG) Tracks 1 and 2. Awards in this category will support fundamental integrative research that addresses technological and social science dimensions of smart and connected communities and pilots solutions together with communities. Track 1 proposals may request budgets ranging between $1,500,001 and $2,500,000, with durations of up to four years. Track 2 proposals may request budgets up to $1,500,000, with durations of up to three years. Note that NSF is working with the Japan Science and Technology Agency (JST) to support joint US-Japan IRG Track 2 proposals (SCC-IRG JST) that address topics related to recovery from COVID-19 and future resilience planning related to pandemics and disasters, including how the proposed research will enable community adjustment to life in the new normal of a post-COVID-19 society.

Trans-Atlantic Platform Recovery, Renewal, and Resilience in a Post-Pandemic World (PD-21-188Y)

Current Closing Date for applications is July 12, 2021

• The Trans-Atlantic Platform Recovery, Renewal, and Resilience in a Post-Pandemic World (T-AP RRR) opportunity supports international, collaborative research projects that address key gaps in our understanding of the complex societal effects of COVID-19. Specifically, T-AP RRR supports research that addresses one or more of the following challenges: reducing inequalities and vulnerabilities; building a more resilient, inclusive, and sustainable society; fostering democratic governance and participation; advancing responsible and inclusive digital innovation; and/or ensuring effective and accurate communication and media.
• Proposals requesting NSF funding must fit within the scientific purview of the NSF Directorate for Social, Behavioral and Economic Sciences (SBE). Proposers are strongly encouraged to consult SBE’s programs and contact the cognizant program director (see Contacts, above) to discuss their proposals’ fit within NSF/SBE’s purview prior to submission of the international team proposal to the T-AP RRR Call.
• T-AP RRR supports collaborative research teams from four continents: Africa (Republic of South Africa); Europe (Croatia, Finland, France, Germany, Poland, Switzerland, and the United Kingdom); North America (Canada, the United States); and South America (Brazil and Colombia). Teams must include researchers based in at least three participating T-AP RRR countries and must include partners from both sides of the Atlantic, i.e., from Europe/Africa and the Americas. Research partners will receive funding from their own national funding agencies for projects of up to 36 months in duration.

Other HHS Funding Opportunities

Biomedical Advanced Research and Development Authority (BARDA) BAA Amendment (BAA-18-100-SOL-00003_Amendment_13)
Applications accepted until 4/30/20 at 3:30 PM Central

• BARDA is soliciting applications for topics specifically relating to COVID-19, including diagnostic assays, point-of care-diagnostic assays, vaccines, therapeutics, prophylaxis, respiratory protective devises, and ventilators.

AHRQ Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

• Agency for Healthcare Research and Quality is particularly interested in understanding how digital health innovations contributed to health system and healthcare professional innovation and challenges and solutions to meeting the needs of vulnerable populations including older adults, people living with multiple chronic conditions, rural communities, and uninsured and underinsured populations. AHRQ will encourage multimethod, rapid-cycle research with the ability to produce and disseminate findings as early as 6 months.

Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (NOT-HS-20-008)

• AHRQ intends to publish a new funding opportunity announcement using the R01 mechanism to support novel, high-impact studies evaluating health system and healthcare professional responsiveness to COVID-19.  This Notice is being provided to allow potential applicants sufficient time to develop responsive applications

Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) (RFA-HS-20-003)
Applications due 6/15/20

• This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic.

RFP — AMENDMENT — BARDA’s Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement  (BAA-20-100-SOL-0002)
Abstract submissions due by 6/30/20 at 4:00 PM Central

• AOI #4 will be open for abstract submissions. Award(s) expected to be made under these Special Instructions 003 will be less than $750,000 in total government funding. Preliminarily, a call with the relevant Program Manager is strongly encouraged prior to any submission to better understand the program objectives for AOI #4.

Centers for Disease Control and Prevention

Monitoring Cause-specific School Asenteeism for Estimating Community-wide Influenza and SARS-CoV-2 Transmission (WUSTL Key Required)

Internal Selection Deadline is 10/15/2020 (OPEN); Applications due to CDC 12/18/2020

• The purpose of this notice of funding opportunity (NOFO) is to support a research project that aims to develop and implement an influenza-like illness (ILI)-specific student absentee monitoring system in kindergarten through twelfth grade (K-12) schools and assess its usability for early detection of influenza, SARS-CoV-2, and other respiratory pathogen transmission in schools and surrounding communities. To achieve this aim, the project team will: 1) rapidly determine the causes of school absenteeism in students across selected school district(s) over a three-year period; 2) detect within-household transmission of influenza and SARS-CoV-2 in households from which a student has been absent from school due to ILI; and 3) assess comparability between influenza-specific and SARS-CoV-2-specific student absenteeism data from the participating schools and multiple layers of complementary influenza and SARS-CoV-2 surveillance data routinely collected in the health care facilities serving the general population of this school district
• Estimated Total Program Funding is $3M; Award Ceiling is $1M; Award Floor is $500,000.

Emerging Infections Network – Research for Preventing, Detecting, and Managing Travelers who Acquire Infectious Disease Abroad (RFA-CK-21-002)

Application Due Date: 12/18/2020

• The purpose of this notice of funding opportunity (NOFO) is to support research activities that will assist with the prevention, detection, and management of international travelers who become ill during or after travel. The project must have a focus on travel and tropical medicine providers with the capability to participate in both research and surveillance to determine the disease prevention strategies, burden, severity, optimal diagnostics, treatment interventions, and outcomes of infectious diseases acquired by travelers while abroad. This research will bridge the gap between clinical medicine and public health by assisting with improving patient care, better understanding the natural history of disease, and implementing optimal diagnostic and treatment strategies, with the ultimate outcome being an advancement in the global health security of the United States.
• Mechanism of Support: U01 – Research Project – Cooperative Agreement
• Funds Available and Anticipated Number of Awards: The estimated total funding available, including direct and indirect costs, for the entire five (5)-year project period is $7,500,000. The number of awards is estimated to be one (1). Awards issued under this NOFO are contingent  upon availability of funds and a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is also  anticipated that the size and duration of each award may also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration and cost of the  applications received.
• Budget and Project Period: The estimated total funding (direct and indirect) for the first year (12-month budget period) is $1,500,000 with individual awards ranging from $1,000,000 to $1,500,000 for the first year. The estimated total funding (direct and indirect) for the entire  project period is $7,500,000. The project period is anticipated to run from 09/01/2021 to  8/31/2026.

US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children (RFA-IP-21-002) (WUSTL Key required) Internal Selection deadline is 12/07/2020 (OPEN); Applications due to CDC 02/8/2021; LOIs due to CDC 01/7/2021.

• The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US  institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations.
• The estimated total funding (direct and indirect) for the first year (12-month budget period) is $13,650,000 with individual awards estimated to range from $1,600,000 to $1,950,000 for all components combined. The estimated total funding (direct and indirect) for the entire project period is $68,250,000. The project period is anticipated to run from 09/01/2021 to 08/31/2026.

CDC Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services (RFA-GH-21-004) (WUSTL Key required) Internal Selection deadline is 12/07/2020 (STILL OPEN); Applications due to CDC 02/18/2021; LOIs due to CDC 01/18/2021.

• The purpose of this NOFO is to understand the needs of emergency-affected and displaced populations and estimate morbidity and mortality in the context of the COVID-19 pandemic. The overall goals of this operational research are to a) improve mortality and cause of death estimation during the acute emergency phase, b) understand COVID-19 disease transmission, contributing factors and secondary health consequences, c) study the effects of various hand hygiene interventions on mitigating the spread of COVID-19 and d) understand the mental health impact of COVID-19 to reduce associated morbidity and mortality among displaced populations and in emergency settings.
• The estimated total funding available including direct and indirect costs, for the entire 5-year project period is $75M. The number of awards will be up to 5.

Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health (RFA-OT18-18020301SUPP21)

Deadline for submission of Application is March 5, 2021

• The purpose of this notice of funding opportunity (NOFO) is to announce the availability of supplemental funding for the organizations that were previously awarded funding under Funding Strategy 1 of CDC-RFA-OT18-1802: Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health. This supplemental funding opportunity will support recipients in delivering capacity-building assistance (CBA) activities to address ongoing needs for the COVID-19 response. The CDC-RFA-OT18-1802 recipients are eligible to submit applications for COVID-19 CIO Project Plans that match the Target Population Category (A, B, or C) and Target Population Description for which they received initial funding in FY18. The COVID-19 CIO Project Plans will be attached to the NOFO once published.
• Estimated Total Program Funding is $750,000; Award Ceiling is $250,000

Strengthening environmental health capacity (EHC) to detect, prevent, and control environmental health hazards through data-driven, evidence-based approaches; pilot Environmental Health Records EHR/COVID-19 community mitigation (CDC-RFA-EH20-2005010SUPP21)

Deadline is July 23, 2021

• The environmental health capacity (EHC) funding opportunity seeks to strengthen the nation’s environmental health (EH) capacity to protect public health by strengthening the capacity of public health departments using 3 strategies to address specific EH topics and issues. This will ensure safe and healthy environments and improve community health status. The 3 strategies are (1) using EH data and information, (2) identifying and addressing EH hazards, and (3) assessing the effectiveness and impact of EH interventions.  All EHC projects must provided activities, objectives, and performance measures that encompases the three primary EHC strategies. 
• This project will be initiated through the CDC environmental health capacity (EHC) project Component C, the purpose of this project is to assess the implementation of COVID-19 community mitigation strategies in communities disproportionately affected by COVID-19. Focus will be on mitigation strategies promoting behaviors that prevent the spread of the virus and maintain healthy environments (e.g., cleaning and disinfection, proper ventilation, safe water systems, etc.). Project objectives include identifying any existing challenges and differences in strategy implementation to prevent COVID-19 transmission and reduce impact among racial and ethnic minority groups, people with lower incomes and/or experiencing poverty or homelessness, low-wage essential workers, and rural communities.
• This project will be initiated through the CDC environmental health capacity (EHC) project Component C, the purpose of this project is to determine the feasibility and utility of environmental health records EHRs to provide access to more current data with a minimal delay between cancer diagnosis and reporting, to serve as a potential source of environmental risk factor data, and to provide more complete data relative to sociodemographic factors to better identify inequities.

Department of Defense Sponsored Funding Opportunities

Defense Logistics Agency’s Technology Accelerator OTA Program
The white paper submission period closes May 4, 2020, at 1:00 EDT.

• DLA seeks novel solutions to combat COVID-19. Specifically, the DoD suffers from an increasing demand for Personal Protective Equipment (“PPE”) for individuals who perform critical national security functions. Of particular concern are N95 masks, which are primarily produced overseas.

NOTICE OF INTENT: MTEC National Emergency Telecritical Care Network (NETCCN) Project

• MTEC will seek proposals for cloud-based, low-resource, stand-alone health information management systems for the creation and coordination of flexible and extendable “virtual critical care wards” based on existing technology in mobile communication and real-time data collection and reporting. MTEC expects to make up to six (6) initial awards to qualified teams to accomplish the initial enhanced development effort.

MTEC Development of Treatments for COVID-19 Technologies
Enhanced White Papers are due by 4/8/2020 at 11:00 AM Central

• The Medical Technology Enterprise Consortium (MTEC) is seeking proposals focused on the development of COVID-19 treatments with potential application to the prevention of infection and therapeutics that can be administered in a non-hospital environment. Military relevance is a critical component of this solicitation.

Wearable Diagnostic for Detection of COVID-19 Infection (MTEC-20-12-COVID-19_Diagnostics)
White papers due May 13, 2020

• The goal of this RPP is to develop a wearable diagnostic capability for the pre-/very earlysymptomatic detection of COVID-19 infection.

Newton Award for Transformative Ideas During the COVID-19 Pandemic (BRO-20-NEWTON)
Open to receive applications continuously until 4:00 p.m. Eastern Time (ET), 15 May 2020

• This award will be presented to a single investigator or team of up to two investigators that develops a “transformative idea” to resolve challenges, advance frontiers, and set new paradigms in areas of immense potential benefit to DoD and the nation at large. Proposals should aim to produce novel conceptual frameworks or theory-based approaches that present disruptive ways of thinking about fundamental scientific problems that have evaded resolution, propose new, paradigm-shifting scientific directions, and/or address fundamental and important questions that are argued to be undervalued by the scientific community.

Interoperable Medical Automated Systems (iMAS) Technology and Gap Assessment
Applications are due 6/18/20

• Request for Project Proposals (RPP) that aims to help develop a research prototype for the ability to telemonitor and capture research data for the following research areas: COVID-19 wards, emergency rooms/trauma rooms (ERs/TRs), and neurological patients. This capability will help develop the Department of Defense’s (DoD’s) interoperable Medical Automated Systems (iMAS) program.

DARPA Young Faculty Award (YFA)

Closing Date for Applications: January 8, 2021

• The Defense Advanced Research Projects Agency (DARPA) Young Faculty Award (YFA) program aims to identify and engage rising stars in junior faculty positions in academia and equivalent positions at non-profit research institutions and expose them to Department of Defense (DoD) and National Security challenges and needs. In particular, YFA will provide high-impact funding to elite researchers early in their careers to develop innovative new research directions in the context of enabling transformative DoD capabilities. The long-term goal of the program is to develop the next generation of scientists and engineers in the research community who will focus a significant portion of their future careers on DoD and National Security issues. DARPA is particularly interested in identifying outstanding researchers who have previously not been performers on DARPA programs, but the program is open to all qualified applicants with innovative research ideas.
• Before preparing an executive summary or proposal submission, proposers are encouraged to review the DARPA mission statement and current program descriptions at the DARPA website to familiarize themselves with examples of current DARPA investments. This is not meant as instruction to duplicate those efforts, but rather to illustrate that current programs are aimed at research that will substantially advance our capabilities in these areas. Once awards are made, each YFA performer will be assigned a DARPA Program Manager with interests closely related to their research topic. The Program Manager will act as project manager and mentor to the YFA award recipients.
• This RA seeks grant proposals for a research activity consisting of a 24-month base period. No award type other than grants will be issued under this RA. Each 12-month interval of the base period shall not exceed $250,000. Proposals should also include a 12-month option period with a maximum funding level of $500,000. The 12-month option period, referred to as the “Director’s Fellowship,” will be reserved for a limited number of awardees who demonstrate exceptional YFA project performance over the 24-month base period. A target start date of July 2021 may be assumed for planning purposes.
• This RA solicits single principal investigator (PI) proposals for research and development in the specific TAs of interest articulated below. Prior to submitting a full proposal, proposers are strongly encouraged to first submit an executive summary as described in Section IV. At the executive summary phase, proposing PIs are limited to one executive summary per TA; at the full proposal phase, proposing PIs are limited to submitting only one full proposal to only one topic under this RA. Submitting more than one full proposal may result in all of the PI’s proposal submissions being determined non-conforming and being removed from award consideration. Potential applicants are encouraged to carefully consider the descriptions of the TAs before submission. Each submission (executive summary or full proposal) must specify ONE and only one TA for the submission and identify this TA on the submission’s cover sheet. Executive Summaries and Full Proposals (limit of one proposal per proposer) that do not clearly address a specific topic may be deemed non-conforming and may not be reviewed. DARPA reserves the right to assign a proposal or an executive summary to a different topic area than indicated by the proposer.
• The TA (#2 out of 27) that mentions COVID-19
  Infectious Disease Detection of Individuals at Facility Ingress
  • Current intake methods for individuals entering into DoD or civilian medical installations rely on patient self-report and memory regarding medical and travel history and current symptomology. These data do not facilitate early warning to medical practitioners. Standard of care for remote detection of illness is limited to temperature measurements obtained via emitted infrared radiation. A need exists for technological solutions to rapidly and remotely (~ <20m) assess incoming individuals in order to detect their infection status.
• In order to address this issue, DARPA is seeking proposals to investigate technological approaches for understanding signatures of infectious disease within individuals, whether symptomatic or not. The specific aims of the work will be to explore novel methods of standoff disease detection by characterizing the specific attributes, or phenomena, indicative of an individual’s infection status. Diseases/pathogens of interest are primarily respiratory illnesses such as COVID-19 (SARS-CoV-2) and Influenza A/B. Supported research will be in the areas of remote inspection of signatures via waveform interaction technologies (e.g., optical, RF, IR, Raman, frequency combs, acoustic, quantum, etc.). Such research will determine whether signature profiles consistent with infection status exist for both symptomatic and asymptomatic individuals and that such profiles can be ascertained via standoff detection. If such signatures exist, it is critical to understand how they change in the presence of confounders such as environmental temperature, clothing, individual demographics, and physical characteristics. Proposals must include a detailed description of the specific hypotheses to be tested, the envisioned use cases, and justification for technical feasibility.

Department of Homeland Security

Innovative Commercial Products in Support of Coronavirus (COVID-19) Response – Commercial Solutions Opening Pilot Program (CSOP)
Proposals are accepted and considered on a rolling basis until 8/31/2020

• The Government seeks to rapidly accelerate the testing and fielding of new capabilities, employing innovative commercial products to the detection of exposure, prevention, containment and treatment of COVID-19 and similar microbial threats.

NASA

Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 pandemic
Applications will be accepted on a rolling basis through 3/29/21

• NASA’s Earth Science Division (ESD) would like to call the attention of the Earth Science research, applications, and data systems communities to Program Element A.28 “Rapid Response and Novel Research in Earth Science” (RRNES) of Research Opportunities in Space and Earth Sciences (ROSES) 2020 as an opportunity to propose investigations making innovative use of NASA satellite data to address regional-to-global environmental, economic, and/or societal impacts of the COVID-19 pandemic.

USDA

National Animal Disease Preparedness and Response Program 2020 Cooperative/Interagency Agreements
Applications are due 9/15/20

• In this funding opportunity, the NADPRP is seeking proposals for projects that will (1) advance capabilities and capacities related to rapid large-scale animal depopulation and carcass disposal in a high-consequence animal disease outbreak, or (2) enhance U.S. livestock biosecurity.

USAID

Connectivity for Learning (RFI-615-21-000002) Kenya USAID-Nairobi

Responses to this RFI must be submitted by March 11, 2021

• Activity Objective: With a variety of stakeholders, USAID/KEA seeks to bridge the digital divide and lack of internet connectivity in schools and communities while embedding the skills needed to help raise reading and social and emotional outcomes for all students in grades 1-3 through sustainable and user-friendly distance learning solutions and resources (both synchronous and asynchronous).
• Activity Synopsis: The goal of the upcoming activity is to implement digital/online distance learning with support from the private sector (Kenyan, US, and international companies) to improve reading and social and emotional skills for all learners in grades 1-3 in a diverse array of Kenyan counties (ASALs, urban/rural areas, etc). The activity will aim to improve reading and social and emotional skills while strengthening local capacity to support and manage distance learning, similar to other existing approaches offered in Kenya (EX:KICD). The activity will have a unique focus on embedding caregivers and teachers with the knowledge, skills, and training to support learners in their homes, and ensuring that the intervention is sustainable beyond the COVID-19 pandemic.

COVID-19 FUNDING REQUESTS AND UNSOLICITED PROPOSALS
Concepts accepted on a rolling basis; Closed July 6, 2020.

• USAID is responding to the COVID-19 pandemic with decisive action at home and abroad. Our priorities in the COVID-19 response are to protect the safety and health security of our global workforce, ensure that we can continue our life-saving mission across the world, and support partner countries in their response to COVID-19. Partners may submit unsolicited proposals to COVID19_Concepts@usaid.gov.

Department of State

Countering Corruption Amid COVID-19 (WUSTL Key required) 
Internal Selections deadline is 5/21/2020. (Sponsor deadline is 6/12/20)​

• The U.S. Department of State, Bureau of Democracy, Human Rights and Labor (DRL) announces an open competition for organizations interested in submitting applications in support of the goal of combatting corruption arising in response to the COVID-19 pandemic.

Boosting Frontline Health Workers’ Ability in Responding to COVID-19 – Virtual Awareness and Capacity Building Training Project (PAS-CMR-FY20-07)
Applications are due 8/10/20

• The U.S. Embassy in Cameroon announces an open competition for organizations to submit applications to support Cameroon’s COVID-19 response, focusing on increasing awareness, motivating informed and constructive action, supporting frontline medical workers, and/or countering misinformation.

DOS The Global Equality Fund (WUSTL Key Required) Internal Selection deadline is 12/21/2020 (STILL OPEN); Applications due to DOS 02/05/2021. Award Floor is $750,000; Award Ceiling is $1,000,000. 

• Applications for projects that provide Lesbian, Gay, Bisexual, Transgender and Intersex (LGBTI) individuals and communities with the tools to empower local movements and communities, prevent, mitigate and recover from violence, discrimination, stigma, and human rights abuses, as well as programs that work to eliminate laws which criminalize LGBTI status and/or conduct. Successful proposals will be funded by the resources of the Global Equality Fund, a public private partnership including the governments of Argentina, Australia, Canada, Chile, Croatia, Denmark, Finland, France, Germany, Iceland, Italy, Montenegro, the Netherlands, Norway, Sweden, Uruguay and the United States, as well as the Arcus Foundation, the John D. Evans Foundation, FRI: the Norwegian Organization for Sexual and Gender Diversity, the M·A·C AIDS Fund, Deloitte LLP, the Royal Bank of Canada, Hilton, Bloomberg LP, Thomson Reuters Foundation TrustLaw Initiative, Human Rights Campaign, and Out Leadership. DRL invites organizations to submit proposals that respond to the Global Equality Fund’s strategic framework, which includes, but is not limited to the following areas:
• Freedom from Violence
• Access to Justice
• Empowered & Inclusive Movements & Organizations Social Inclusion
• Additionally, strong proposals are guided by the following cross-cutting values: 
• COVID-19 Response: We all seek to understand the ways in which COVID-19 is impacting the human rights of people globally, and in particular the rights of the world’s most vulnerable people. Unfortunately, COVID-19 has brought new challenges for LGBTI people and those from other marginalized groups, to include older persons, persons with disabilities, and ethnic and racial minorities, who have been disproportionately impacted by the pandemic. Proposals should share concerns and provide information about plans to address the impact of the pandemic on the LGBTI and other marginalized communities. Proposals can take a creative and flexible approach to addressing programming in the evolving situation. 
• Gender Analysis
• Locally-led LGBTI-Organizations
• Organizational Development and Capacity

Counter misinformation and disinformation about COVID-19 (WUSTL Key Required) Internal Selection deadline is 02/01/2021 (OPEN); Application due to DOS 02/28/2021. Award ceiling is $20,000

• The U.S. Embassy and Consulate in Poland are pleased to announce a Notice of Funding Opportunity (NOFO) for grants of up to $20,000 for projects beginning no earlier than April 2021. The deadline for this NOFO, #WAW-NOFO-FY21-01, is Sunday, February 28, 2021. PROJECT THEMES: This call is for proposals for innovative projects that:
  • Counter misinformation and disinformation about COVID-19, including, but not limited to, information campaigns, social media campaigns, science workshops for journalists, educational activities for students, etc.
  • Counter misinformation and disinformation about the COVID-19 vaccine, including, but not limited to, information campaigns, social media campaigns, training for journalists about the science behind vaccines, educational activities for students, etc.
  • Teach high school and/or university students to think critically about information they see on social media about the COVID-19 pandemic and vaccine, including examining sources, evaluating multiple points of view, and considering the agendas of information sources.
  • Equip educators to teach students to think critically about information they see on social media about the COVID-19 pandemic and vaccine, including examining sources, evaluating multiple points of view, and considering the agendas of information sources.

**Please note: Applications that do not specifically address one of the four topics above will be disqualified.**

ELIGIBILITY:

• Grants will be awarded to local representatives of Polish non-governmental organizations, cultural or educational institutions, media, and individuals whose proposals support the topics listed below.
• All grantees must have a non-profit status.
• One application per organization or individual. Organizations which currently have an open grant from the Embassy should not apply.
• NGOs and individuals from the United States may apply, but should present evidence of a relationship with a local partner operating in Poland in their proposals.
• In order to receive a grant, all organizations (not individuals) must have a DUNS number and a valid SAM.gov registration (registrations are valid for one year). Instructions are in Section F.

Counter misinformation and disinformation about COVID-19 in Malawi
Deadline for applications is March 23, 2021

• The Government of Malawi announced its intention to roll out COVID-19 vaccine distributions to the populace in March.  However, some Malawians are spreading misinformation among the populace, leading to building mistrust and suspicion of the vaccine’s safety, in both rural and urban areas.  This misinformation is being spread on popular social media platforms, and word of mouth.   The objective of the grant would be to spread more positive messages about COVID-19 vaccination at a grassroots, non-governmental level in Malawian communities. Length of performance period is 3 to 6 months; number of awards anticipated is 1; Award of up to $50,000. Note: Only projects that take place in Malawi will be considered. PAS encourages applicants to provide cost-sharing from additional sources in support of the proposed project.
• This call is for proposals for innovative projects that (Please note: Application that do not specifically address one of the four topics will be disqualified):
  • Counter misinformation and disinformation about the COVID-19 vaccine, including, but not limited to, information campaigns, social media campaigns, training for journalists about the science behind vaccines, educational activities for students, etc.
  • Teach communities where COVID-19 vaccine skepticism is observed, to think critically about information they see on social media about the COVID-19 pandemic and vaccine, including examining sources, evaluating multiple points of view, and considering the agendas of information sources.
  • Equip educators to teach students in rural and underserved areas to think critically about information they see on social media about the COVID-19 pandemic and vaccine, including examining sources, evaluating multiple points of view, and considering the agendas of information sources.
  • Achieve an increase in the number of  Malawians, those who previously expressed suspicion and even rejection of COVID-19 vaccines, reporting a change of attitude and now positive reception to the idea of being vaccinated. 
  • Achieve an increase in the number of Malawians receiving the vaccine, in areas where vaccine skepticism was earlier observed. 

COVID-19 Private Sector Engagement & Partnership Fund (SFPO0007088)

Deadline for applications is August 27, 2021

• The U.S. Department of State, Office of Global Partnerships (E/GP) is pleased to announce the COVID-19 Private Sector Engagement & Partnership Fund (Fund) Annual Program Statement (APS) that will be used make assistance awards. This APS is being done in partnership the U.S. Agency for International Development and concept papers may be transferred to the Agency based upon a determination of suitability for award and administration.
• USAID’s policies and procedures will apply to concept papers that are transferred to the Agency. This APS utilizes a two-step process. Applicants must first submit a concise (5-page) concept paper designed to clearly communicate their program idea and objectives. This is not a full proposal. The purpose of the concept paper is to allow applicants to submit program ideas for evaluation prior to requiring the development of a full proposal application. After merit review of eligible concept papers, selected applicants will be invited to expand on their program idea(s) by submitting a full proposal application. Full proposals will go through a second merit review before a final funding decision is made. E/GP has outlined the process through which potential applicants may apply in Appendix 1 to this APS.
• Through this APS, the Department of State (DOS) announces its desire to engage private sector partners to expand and amplify the Department’s COVID-19 response. The Fund seeks to support private sector interventions and build upon private sector investments in response to the virus. The DOS broadly categorizes the private sector to include: U.S. corporations, foreign corporations, foundations, faith-based organizations, non-governmental organizations, civil society groups, Diaspora groups, service organizations, universities and other institutions of learning.
• The Fund is designed to support specific Administration and Department priorities and criteria for leveraging private sector led responses to the COVID-19 virus. This APS will accept concept papers throughout the open period. The Department will utilize a rolling review schedule, please refer to Section D.4.
• Total Amount available is $10,000,000. Anticipated amount range is $50,000 to $1,000,000, however, concept papers over this amount will be considered. Length of performance period is 12 to 36 months.

Department of Justice

COVID 19 – Operational Challenges for Corrections
Applications are due 8/27/20

• The National Institute of Corrections (NIC) is seeking applications for funding under the Fiscal Year (FY) 2020 to support knowledge sharing around the nationwide correctional challenges that prisons, jails, and community services face during the COVID19 pandemic.

Department of Labor

Workplace Safety and Health Training on Infectious Diseases, Including COVID-19 (SHTG-FY-21-05)

Deadline is July 26, 2021

• Under the authority of Section 21 of the Occupational Safety and Health Act of 1970 (OSH Act), the U.S. Department of Labor (DOL) Occupational Safety and Health Administration (OSHA) established its discretionary grant program in 1978. In 1997, OSHA renamed the program in honor of the late Susan Harwood, former director of the OSHA Office of Risk Assessment. The grant program offers opportunities for nonprofit organizations to compete annually for funding so they may develop and conduct training and educational programs for small business employers and workers on the recognition, avoidance, and prevention of occupational safety and health hazards in their workplaces, and to inform workers of their rights and employers of their responsibilities under the OSH Act.
• The American Rescue Plan Act (ARPA) of 2021 appropriated $200,000,000 to the Secretary of Labor for specified agencies to carry out COVID-19-related worker protection activities and allocated not less than $100,000,000 of those funds for OSHA. ARPA also specified that $10,000,000 of OSHA’s funds be for Susan Harwood training grants.

Environmental Protection Agency

State Environmental Justice Cooperative Agreement Program (SEJCA)/ COVID-19 Projects
Applications due June 30

• EPA is giving a special consideration to those applications aimed at addressing the impacts of the COVID-19 pandemic on urban and rural low income and minority communities. EPA anticipates making five awards in amounts of up to $200,000 per award for a two-year project period. EPA encourages applicants to develop innovative plans and processes to conduct effective outreach to underserved communities in the midst of social-distancing and local stay-at-home orders, especially in places where internet access may not be readily available to all residents.

EPA Environmental Justice Collaborative Problem-Solving (EJCPS) Cooperative Agreement Program (PLEASE NOTE: Colleges and Universities are INELIGIBLE to receive an award but the EPA encourages other organizations to partner with colleges and universities, as appropriate).  (EPA-OP-OEJ-21-02)

Deadline for submission is May 7, 2021

• The total estimated funding for this competitive opportunity is approximately $3,200,000. EPA anticipates awarding a total of twenty cooperative agreements of approximately $160,000 each within the 10 EPA Regions, subject to availability of funds, the quality of applications received, and other applicable considerations. Funded assistance agreements will have a two-year project period. Applicants should plan for projects to start October 1, 2021.
• A key starting point for any collaborative problem-solving project is the identification of an environmental and/or public health issue and the community’s leadership in formulating goals (e.g., diesel reduction, lead abatement, reducing high incidence of asthma, land use changes, pollution prevention, implementation of fish advisories, hazardous waste, emissions reduction, risk reduction, community cleanups, or compliance with local environmental and/or public health regulations, etc.). Collaborative problem-solving involves the establishment and/or maintenance of partnerships between and among other stakeholders and the underserved community to address the community’s local environmental and/or public health issues.
• For this competition, EPA may give special consideration to high ranking applications that focus on the following program priorities:
• Public Education, Training, Emergency Planning, and/or Investigations on Impacts of COVID-19 on Underserved Communities and Vulnerable Populations– EPA may give special consideration to projects that address the impacts that the current COVID-19 pandemic has on vulnerable populations. Applicants may use funding to conduct public education, training, outreach, investigations and/or develop plans and programs to specifically work on mitigating the impacts of COVID-19 on EJ communities. Applicants are encouraged to develop innovative plans and processes to conduct effective outreach to underserved communities in the midst of social-distancing and local stay-at-home orders, especially in places where internet access may not be readily available to all residents. To qualify for this special consideration, applications must address the impacts of COVID-19 through eligible activities (see Section I.) Examples of eligible activities include (but are not limited to) 1) sharing information related to EPA-approved disinfectants to combat COVID-19 (List N: Disinfectants for Use Against SARS-CoV-2), 2) addressing underserved residents’ increased exposure to in-home pollutants and healthy housing issues as an unintended consequence of local stay-at-home orders, and 3) training of community health workers as community educators for environmental justice communities. NOTE: EJSG funds cannot be used for Human Health Studies, including taking blood or other medical information from humans.
• Projects addressing Climate, Disaster Resiliency, and/or Emergency Preparedness – The effects of climate change and extreme weather events tend to adversely impact the most vulnerable communities and populations disproportionately. Therefore, EPA may give special consideration to projects that address the needs of underserved and vulnerable communities that have been adversely impacted or are likely to be adversely impacted by natural disasters, including, but not limited to, hurricanes, tornadoes, wildfires, floods, earthquakes, and future pandemics.
• New applicants and grantees – High ranking applicants who have never received an EPA EJCPS award may receive additional consideration during the selection process in order to broaden the universe of EJCPS grantees.

Environmental Justice Small Grants Program (PLEASE NOTE: Colleges and Universities are INELIGIBLE to receive an award but the EPA encourages other organizations to partner with colleges and universities, as appropriate).  (EPA-OP-OEJ-21-01)

Deadline is May 7, 2021

• The Environmental Justice Small Grants (EJSG) Program provides funding directly to eligible applicants for projects that help residents of underserved communities understand and address  local environmental and public health issues. For purposes of this announcement, the term “underserved community” refers to a community with environmental justice concerns and/or vulnerable populations, including people of color, low income, rural, tribal, indigenous, and homeless populations that may be disproportionately impacted by environmental harms and risks. In general, the EJSG program awards grants that support community-driven projects designed to engage, educate, and empower communities to better understand and address local environmental and public health issues. Community-driven projects are projects that include activities where community residents and/or representatives are integrally involved in the thinking behind and execution of those activities. Therefore, applying organizations should have a direct connection to the underserved community impacted by environmental harms and risks.

Health Resources and Services Administration (HRSA)

HRSA Regional Telehealth Resource Center Program (HRSA-21-022) (WUSTL Key required) Internal Selection deadline is 11/12/2020 (STILL OPEN); Applications due to HRSA 01/21/2021.

• This notice announces the opportunity to apply for funding under the Regional Telehealth Resource Center (RTRC) Program. RTRCs assist health care organizations, health care networks, and health care providers in the implementation of cost-effective telehealth programs to serve rural areas and populations. RTRCs also assist patients and families living in rural areas with telehealth technology to obtain health services. This notice of funding opportunity (NOFO) will support 12 RTRCs that focus on statewide and regional telehealth activities as shown below. RTRCs will serve as focal points for advancing the effective use of telehealth technologies in their respective communities and states.
• Estimated Total Program Funding: $3,900,000. Award Ceiling is $325,000. 

HRSA Rural Health Clinic Technical Assistance Program (WUSTL Key required) Internal Selection deadline is 11/12/2020 (OPEN); Applications due to HRSA 01/21/2021.

• This notice announces the opportunity to apply for funding under the Rural Health Clinic Technical Assistance Program. The purpose of this program is to:
  • Identify key policy issues and knowledge gaps among RHCs about topics including regulatory and program compliance, billing and reimbursement, quality improvement, best practices around disease management and care coordination, and RHC policy priorities;
  • Identify tools, resources and strategies to address policy issues, knowledge gaps and other challenges faced by RHCs; and
  • Inform RHCs and other rural stakeholders about key RHC issues that affect, or have the potential to affect, care delivery.
• HRSA estimates approximately $100,000 to be available annually to fund one recipient.

HRSA National Telehealth Resource Center program (HRSA-21-023) (WUSTL Key required) Internal Selection deadline is 11/12/2020 (OPEN); Applications due to HRSA 01/21/2021.

• This notice announces the opportunity to apply for funding under the National Telehealth Resource Center (NTRC) Program. The purpose of NTRCs is to support the delivery of telehealth technical assistance through Regional Telehealth Resource Centers (RTRCs). Two NTRCs may be funded.

On January 31, 2020, the Secretary of the U.S. Department of Health and Human Services declared a public health emergency in response to COVID-19. Should the public health emergency still be in place at the time of this funding notice, and in response to this public health emergency, you may include COVID-19 related activities in your application. Activities could include increased emphasis on support of telehealth directly to consumers or telehealth for public health emergency response. Applicants that focus on such emergency use of telehealth should also outline plans to shift priorities for changing needs and uses of telehealth.

IARPA

IARPA COVID-19 Seedling Research Topics
Applications are due 7/7/20

• IARPA seeks high-risk/high-payoff research programs for these technology needs relevant to the COVID-19 pandemic: detection and sensing; supply chain management and integrity; geo-spatio-temporal monitoring and mapping, with privacy protection; information reliability and collaboration tools; modeling, simulation, and predictive analytics

Agriculture and Food Research Initiative (AFRI)

STOP Spillover
Internal Selection Deadline 5/12/20

• USAID’s STOP Spillover program aims to reduce the spillover of emerging zoonotic viruses from wildlife to people and reduce the amplification and spread of zoonotic viruses in people after they have spilled over from wildlife. USAID plans to fund 1 award up to $100,000,000.

DOD Peer Reviewed Medical Research Program–Investigator-Initiated Research Award (for Emerging Viral Diseases and Respiratory Health)
Pre-applications are due by 5/28/20

• The US Army Medical Research and Development Command (USAMRDC) and the Congressionally Directed Medical Research Programs (CDMRP) are pleased to announce four additional dedicated Program Announcements (PAs) for the FY20 Peer-Reviewed Medical Research Program (PRMRP) that are focused on COVID-19 and SARS-COV-2. These special COVID-19 PRMRP PAs will invest approximately $75M of the FY20 PRMRP $360M appropriation in COVID-19 related research.

DOD Peer Reviewed Medical Research Program–Technology/Therapeutic Development Award (for Emerging Viral Diseases and Respiratory Health)
Pre-applications are due by 5/28/20

• The US Army Medical Research and Development Command (USAMRDC) and the Congressionally Directed Medical Research Programs (CDMRP) are pleased to announce four additional dedicated Program Announcements (PAs) for the FY20 Peer-Reviewed Medical Research Program (PRMRP) that are focused on COVID-19 and SARS-COV-2. These special COVID-19 PRMRP PAs will invest approximately $75M of the FY20 PRMRP $360M appropriation in COVID-19 related research.

xTech COVID-19 Ventilator Challenge
Submissions are due May 31.

• The Department of the Army invites applications to its xTech COVID-19 Ventilator Challenge to develop a low-cost, readily manufacturable emergency ventilator to quickly augment ventilator capacity during the COVID-19 pandemic. Multiple awards with a combined total of up to $1 million may be made. Eligibility is unrestricted.

Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural Systems (A1711)
Applications accepted by 6/5/20

• The COVID-19 pandemic is impacting the nation’s food and agricultural systems. Currently, data is needed to reliably guide decision-making that are supported by scientific evidence. This program area priority addresses the need to develop and deploy rapid, reliable, and readily adoptable strategies across the food and agriculture enterprise in response to the COVID-19 pandemic.

Veterans Health Administration

VHA Innovation Ecosystem and precisionFDA COVID-19 Risk Factor Modeling Challenge
Challenge ends 7/3/2020

• The Veterans Health Administration (VHA) Innovation Ecosystem and Food and Drug Administration (FDA) call on the scientific and analytics community to develop and evaluate computational models to predict COVID-19 related health outcomes in Veterans.

National Council on Disability

COVID-19’s Broadscale Impact on the Lives of People with Disabilities
Applications are due 8/21/20

• NCD seeks proposals for a cooperative agreement to develop NCD’s annual progress report which will examine COVID-19’s broadscale impacts on the lives of people with disabilities in seven major areas: nondiscriminatory access to healthcare; the direct care workforce; group housing; education; employment; mental health; and communications. The report will also include a discussion of the intersection of disability and race, and of transportation impacts.

NIST

NIST Manufacturing USA National Emergency Assistance Program (2020-NIST-MFGUSA-NEAP-01)
Applications will be accepted on rolling basis; closing October 5, 2020.
(Washington University is not eligible as the lead institution but may participate on an application.)

• National Institute of Standards and Technology (NIST) invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic.  Projects may include medical countermeasures; non-medical countermeasures; leveraging institute capabilities to strengthen state and community resilience; grants to companies and technical support to accelerate productions of critical materials, equipment, and supplies; creation of additional production facilities; technology roadmapping for pandemic response and recovery; reshoring the manufacture of critical conventional drugs and ensuring supply chain for critical materials related to pandemic response; or workforce development and training for a skilled advanced manufacturing workforce.

Clinical and Translational Science Awards Limited Funding Opportunities

Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
Application due dates depend on grant mechanisms, expires July 10, 2021.

Non-Federal Opportunities

AHA Rapid Response Grant: COVID-19 and its Cardiovascular Impact
Applications accepted until 4/6/20 at 5 PM Central

• The American Heart Association is accepting applications for an unprecedented rapid response call for cardiovascular/cerebrovascular research proposals to address the growing crisis of the COVID-19 pandemic. The Association is offering fast-tracked research grants for short-term projects that can turn around results within 9-12 months to better understand the diagnosis, prevention, treatment and clinical management of COVID-19 as it relates to heart and brain health.

LifeArc COVID-19 Fund
Applications accepted until 4/6/20

• LifeArc is calling for applications for therapeutics that could be repurposed or repositioned for use in COVID-19 patients. The primary purpose is to accelerate availability of treatments for patients and it is therefore expected that applicants will already have material available for testing and a plan for rapid scale up of clinical material.  Priority will be given to projects that have a clear path and availability for patients in a 6 -12 month time frame.

Children, Screens and COVID-19
Proposals may be accepted until 5/11/20

• Children and Screens is interested in studies that assess the positive and negative impact the role that screens play in families’ lives as a result of the COVID pandemic. For example, during the pandemic screens are relied upon for distance learning and are the sole means of maintaining social connections. How well are they performing in this regard? What approaches have proven effective and for which populations? Conversely, relaxed limits on screens may increase the prevalence of compulsive use, anxiety, depression and other untoward effects previously attributed to digital media. This challenge grant ($100K) is intended to leverage and augment existing cohort studies.

AXA Research Fund: Mitigating Risk in the Wake of the COVID-19 Pandemic
Application will be accepted on a rolling basis until 5/7/20

• This Research Fund is opening a call for projects in areas of protecting vulnerable populations from epidemics and catastrophes, including COVID-19, improving data collection and quality in health, understanding the effects of confinement and social distancing, early warning and preparedness and preserving the environment and our health. There is a limit of one application per department.

American Psychological Foundation – APF COVID-19 Rapid Response Grant
Applications are accepted until 5/1/20

• Up to $20,000 to support psychological research in response to the COVID-19 pandemic.

Elrha – RESEARCH TO SUPPORT COVID-19 RESPONSE IN HUMANITARIAN SETTINGS
Applications accepted in rounds until 5/3/20

• This Call focuses on identified priorities related to the current COVID-19 outbreak in humanitarian settings* in low and middle-income countries (LMICs). Proposals will be eligible for research that targets:
  • Refugees or IDPs in camps or urban humanitarian settings, or conflict-affected people in humanitarian settings in LMICs
  • Health systems and health care workers supporting the COVID-19 response in humanitarian settings in LMICs.

Harrington Discovery Institute
Applications due April 30, 2020

• Harrington Discovery Institutes seeks to accelerate programs in its current portfolio that may target Coronavirus and its clinical ramifications, particularly on the lungs and heart. This entails advancing treatments that may enter clinical trials right away. They also seek to aggressively seek broad spectrum antivirals that may avert the next viral pandemic.

C3.ai DTI COVID-19 Research Award
Proposals must be submitted before 5/1/20 but submissions before 4/15/20 will be reviewed for early potential award notification.

• PIs must be researchers from the C3.ai DTI consortium member institutions, but Washington University faculty can serve as Co-Investigators. This call for proposals focuses on understanding and mitigating the spread of COVID-19, improving the ability of the public health and medical establishment to respond, and minimizing the impact of this disease on society. The interests of C3.ai DTI are in the use of AI/ML, data analytics, cloud computing, and change management to mitigate the course and impact of the disease.

Internet Society Foundation
Applications accepted until 5/17/20

• We recognize the importance that the Internet plays during this uncertain time, serving as a lifeline that enables children to continue learning; families and friends to stay connected; and vital public health information to keep circulating. The Foundation is committed to working with organizations that take known Internet-based technical solutions and apply them to COVID-19 responses or are pivoting from their “regular” activities to create new projects or reworked technical solutions that respond to the pandemic. Grants of $250,000 to $500,000 USD will be awarded for projects lasting up to 12 months.

Johnson and Johnson Drug Resistant Tuberculosis Lifeline QuickFire Challenge
Deadline is 5/19/2020

• J&J is seeking innovative proposals for creative, easy-to-implement ideas with the aim to solve for the continuity of DR-TB services during the pandemic and after, since health systems will take time to return to efficiency.  Submissions should address continuity of DR-TB care for patients in high-burden countries (e.g., India, Indonesia, Philippines, South Africa, Ukraine).  Up to five innovators with the best ideas, technologies, or potential solutions could be awarded grant funding from a total of $250,000*

United States – India Science and Technology Endowment Fund COVID-19 Ignition Grants
Applications due on  5/15/2020

• The United States–India Science & Technology Endowment Fund (USISTEF) seeks to support and foster joint applied R&D to generate public good through the commercialization of technology developed through sustained partnerships between U.S. and Indian researchers and entrepreneurs. USISTEF encourages out-of-the-box, innovative ideas from the community to address the COVID-19 challenge. Ignition Grant proposals should address proof-of-concept based on sound science and engineering research, potential for commercial viability and practicality of the idea/innovation/technology.

Alkermes COVID-19 Relief Fund to Support Innovative Programs Helping Vulnerable Patient Communities 
Deadline is 05/20/2020

• Alkermes Inspiration Grants program will provide up to a total of $500,000 in grants to assist nonprofit organizations in their work to urgently address COVID-19-related needs for people living with addiction, serious mental illness or cancer.

American Diabetes Association COVID-19 and Diabetes Research Call for Applications.
The COVID-19 and Diabetes Research Awards expedited application deadline will be 5pm ET on May 22, 2020 for July 1, 2020 funding.

• The American Diabetes Association (ADA) is requesting applications (see RFA) for research focused on the impact of diabetes on COVID-19 and the impact of COVID-19 on diabetes and its complications. The goal of this RFA is to use a rapid application and review process to identify at least 10 grants of up to $100,000/each in this area and of high scientific merit for immediate funding.

COVID-19 Targeted PFA
Full applications will be due Tuesday, May 26, 2020, by 5:00 p.m. ET

• In order to respond to the COVID-19 pandemic, PCORI is issuing a new research funding announcement with an accelerated timeline to support innovative, high-impact studies that fit clearly within our core mission of patient-engaged and patient-centered comparative clinical effectiveness research. The objectives of this announcement are to (1) strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and (2) provide evidence to inform clinical and public health responses, decision making, and planning.

Facebook Research – Economic Impact of Digital Technologies Request for Proposals
Applications accepted until 5/20/20

• When growth is challenged by economic contraction or other disruptive circumstances (such as COVID-19), digital technologies may offer businesses the means to quickly adjust their practices, enabling them to minimize adverse impacts and remain resilient. Facebook is interested in supporting projects that address the economic consequences and implications of developing digital technologies for small businesses.

Pfizer COVID-19 Competitive Grant Program
Applications accepted by 5/22/20

• Pfizer requests proposals in two caterories: Category A: Independent Medical Education Grants; and Category B: Quality & Process Improvement Grants.

Russell Sage Foundation Research Grants       
Letters of inquiry accepted for 5/21/20 deadline

• Because of the effects of COVID-19 on all facets of American life, the Russell Sage Foundation is changing its immediate priorities for letters of inquiry for the May 21, 2020, deadline. For this deadline, RSF will only consider LOIs that satisfy at least one of the following criteria: The research is so timely and time-sensitive that the project must start before April 1, 2021; or the research analyzes social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States.

The Rheumatology Research Foundation
Letter of Intent deadline is 6/1/20

• The Rheumatology Research Foundation is issuing a notice of special interest (NOSI) to highlight the availability of funds for projects exploring the relationships between rheumatic and musculoskeletal diseases and SARS-CoV-2, the virus that causes COVID-19

Health Effects Institute (HEI) Air Pollution, COVID-19, and Human Health
Mandatory letter of intent (LOI) due June 8th.

• HEI solicits applications for research on novel and important aspects of the intersection of exposure to air pollution and COVID-19 health outcomes: (1) Accountability research: What are the effects of the unprecedented interventions taken to control the COVID-19 pandemic on emissions, air pollution, and human health? (2) Susceptibility factors: Are individuals/populations who have been chronically or acutely exposed to higher levels of air pollution at greater risk of mortality from COVID-19 compared to those exposed to lower levels of air pollution? Do the effects differ by race/ethnicity or by measures of socioeconomic status?

Emergency Medical Foundation
Proposals are due 6/5/20

• The Emergency Medicine Foundation is awarding funding of up to $100,000 in new research grants on emergency medicine areas related to COVID-19. 

Booz Allen Foundation: Innovation Grant
Applications accepted until 6/5/20

• The Booz Allen Foundation has established a $1 million Innovation Fund to help nonprofits, entrepreneurs, thought leaders, innovators at colleges and universities, and startups and small businesses harness the power of data, technology, and diverse intellectual capital to improve COVID-19 relief efforts and make a difference. The Foundation is specifically targeting solutions and projects that will build lasting community resilience through protecting vulnerable populations and frontline workers or providing for the safe return to work. Nonprofits can apply for grants of up to $100,000.

American Lung Association COVID-19 Action Initiative
Deadline to submit an application is May 30, 2020 (11:59 PM ET)

• ALA is soliciting proposals for COVID-19 and Emerging Respiratory Viruses Awards ($100,000 per year for up to two years). They are looking for outstanding investigators who can advance our knowledge of COVID-19 and other novel respiratory viruses with pandemic potential.

Social Science Research Council (SSRC)
Applications are due 6/1/20

• The Social Science Research Council (SSRC), as part of its Covid-19 Initiative, seeks proposals from across the social sciences and related fields that address the social, economic, cultural, psychological, and political impact of Covid-19 in the United States and globally, as well as responses to the pandemic’s wide-ranging effects.

Spencer Foundation
Application on a rolling basis until 6/8

• Spencer Foundation is issuing a call for proposals for a COVID-19 Related Special Grant Cycle to support education research projects that will contribute to understanding the rapid shifts in education in this time of crisis and change.

St. Louis CARES Humanitarian Response Program
RFPs submissions are due by 5 p.m., 6/17/20

Approximately $9.5 million will be allocated through the St. Louis CARES Humanitarian Response Program. The goal of the program is to fund program and services that support the needs of County residents suffering from the effects of the COVID-19 public health emergency in order to promote recovery for the region and mitigate the effects of the pandemic. A full list of eligibility requirements can be found here, along with the link to the application.

Pfizer Vaccine Preventable Diseases – COVID-19
Applications are due 6/17/20

• The intent of this Request for Proposal (RFP) is to support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. We are particularly interested in supporting research in the following areas:
  • Understand impact of COVID on communities, spectrum of disease in communities, and level of herd immunity
  • Postmortem Analysis of deceased persons with known or suspected COVID-19

Social Data Research Fellowships
Applications are due 6/16/20

• This grant opportunity’s primary emphasis is related to social media and the 2020 elections, however applications that investigate the impact of the coronavirus pandemic as it intersects with the core themes outlined in the grant description are particularly encouraged. For example, explorations of policy debates, news, or disinformation circulated via social media on topics relevant to the 2020 US elections and amplified by circumstances related to Covid-19–such as vote-by-mail debates, health care policy, Covid-19 disinformation campaigns related to the election, and so on–are welcome. Grants are up to $50,000.

American Thoracic Society and Glaxso Smith Kline Research Grant in COVID-19
Applications due 6/23/20

• Assistant Professors conducting research directly related to COVID-19 are encouraged to apply. The focus of this research grant is proposals that have a high likelihood to advance the understanding of the pathobiology and clinical implications of COVID-19.

Emergency Response for the Health Care System Innovation Challenge
Phase 1 deadline is 6/12/20

• Can you create a digital tool supporting the health care system (including but not limited to providers, government, and public health and community organizations) during a large-scale health crisis (pandemic, natural disaster, or other public health emergency)?

Emergency Response for the General Public Innovation Challenge
Phase 1 deadline is 6/12/20

• Can you build a health technology tool to support the needs of individuals affected by a large-scale health crisis (pandemic, natural disaster, or other public health emergency)?

Microsoft AI for Health COVID-19 Grant Form
Grant applications will be accepted until June 15th, 2020 or until further notice.

• Given the urgency of the COVID-19 crisis, we are accepting requests in the AI for Health program for COVID-19 grant proposals from nonprofits, academia, and governments. This is a focused effort for COVID-19 grant requests only.  This grant program provides Azure cloud and High-Performance Computing capabilities. 

MIT Solve’s 2020 Global Challenges
Deadline to submit a solution is 6/18/20

• Solve is also seeking solutions that focus on preventative and mitigation measures that strengthen access to affordable primary healthcare systems, enhance disease surveillance systems, and improve healthcare supply chains.

The Urban Institute – From COVID-19 Response to Equitable Recovery: A Call for Research and Action to Boost Workers’ Economic Security and Mobility
The deadline to respond to both the RFP and the RFI is 11:59 pm ET, June 29, 2020.

• To achieve these objectives, we are issuing both a Request for Proposals (RFP) and a Request for Information (RFI) to identify and accelerate innovative solutions—including programs, policies, and practices—that not only provide immediate economic relief to struggling workers and those who are out of work, but also create pathways for greater economic security and upward mobility in the long term. The RFP is designed for those with research projects in need of funding, while the RFI is designed for those who have identified promising, scalable practices in need of additional support and/or research and evaluation.

SMDM COVID-19 Decision Modeling Grant
Applications are due 6/30/20

The Society for Medical Decision Making (SMDM) is leading a collaboration to offer the COVID Decision Modeling Initiative (CDMI), which will support the development of decision models to inform the urgent needs of decision makers responding to the Covid-19 pandemic

Special Call for COVID-19 Related Projects Focused on the Federal Nutrition Assistance Programs
Applications are due 7/1/20

• Healthy Eating Research, a national program of the Robert Wood Johnson Foundation, has a limited amount of rapid-response research funds available to commission: 1) issue briefs/ commentaries or papers/research reviews and; 2) small studies to explore the impact of the coronavirus pandemic on nutrition and diet quality, food security, and related health consequences for children and families

The COVID-19 Detect & Protect Challenge​
Submissions close on 06/30/20 at 12:00 AM PT

• A panel of judges will review and select the top 10 open source solutions on a rolling basis through 2020. Winners will receive global recognition and variety of awards for their contribution to society and humankind. Using the UNDP’s vast global network and resources from all supporting partners, we’ll work with the winning creators on the best way to transfer the knowledge to those who need it most. This challenge has three priority actions: (1) Design replicable, low-cost tools to aid in coronavirus detection; (2) Flatten the curve in communities with preventive solutions ; (3) Reduce the disease’s impact on economies of these vulnerable areas 

Amazon Web Services Diagnostic Development Initiative (AWS DDI)
Applications accepted until 6/30/20

• The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.

Data.org Inclusive Growth and Recovery Challenge
Applications are due 7/17/20

• Data.org, in partnership with the Mastercard Center for Inclusive Growth and The Rockefeller Foundation, invites applications to its Inclusive Growth and Recovery Challenge seeking breakthrough ideas that harness the power of data science to help people and communities thrive especially in the wake of COVID-19’s economic impact. Up to 10 awards with a combined total of up to $10 million may be made. Eligibility is unrestricted

Foundation for Opioid Response Efforts. Strengthening Access to Care for Opioid Use Disorder Patients During the COVID-19 National Public Health Emergency: Recovery Support Services
Applications are due 7/31/20

• FORE will initiate rapid response grant support for specific projects that aim to strengthen access to evidence-based OUD recovery services for vulnerable and high-risk populations during the COVID-19 national emergency. This RFP targets projects which can provide recovery support services in the context of social distancing and infection control, including promotion of remote, digital, and virtual forms of recovery support to reach vulnerable and broader populations

Gilead COVID-19 RFP Program: COMMIT™ (COvid-19 unMet MedIcal needs and associated research exTension)
Letter of intent applications are due 8/3/20

• In an effort to further address the unmet medical need in COVID-19, Gilead Medical Affairs is launching the COMMIT program. The COMMIT program will support well defined individual projects of no more than $250,000 USD. Gilead will consider support for research proposals that meet one of the following criteria: (1) Expand data on clinical course and outcome in vulnerable populations; (2) Long-term sequelae (i.e., pulmonary fibrosis, neurologic, cardiac, quality of life); (3) Real world safety and effectiveness of remdesivir used alone or with other agents.

St. Louis County Domestic Violence Response Fund – RFP
Applications are due 8/10/20

• County Executive Dr. Sam Page announced the creation of the COVID-19 Domestic Violence Response Fund, which allocates $1 million of CARES funds to support organizations responding to domestic violence.

Genetech – Call for Grants Notification (CGN): 2020 Health Equity Innovations Fund
Letter of Intent is due on 8/10/20

• The Health Equity Innovations Fund invites proposals to support groundbreaking efforts to address healthcare disparities for historically underserved communities, with a focus on communities of color. Proposals specifically exploring care delivery innovation needs presented by the COVID-19 pandemic (e.g., expansion of telemedicine and technology innovation, use of community health workers, reimagining site of care) are encouraged.

TD Bank Ready Challenge
Applications are due 8/13/20

• TD Bank invites applications to its 2020 TD Ready Challenge supporting organizations that are developing innovative solutions to address the impacts of the COVID-19 pandemic, with a focus on sustainable and equitable recovery. Organizations must also address one or more of the four drivers of change of the TD Ready Commitment: Financial Security, Vibrant Planet, Connected Communities, and Better Health. Multiple one-time grants between $260,000 to $745,000 may be made. Please see the following link for detailed eligibility information.

Robert Wood Johnson Foundation – Systems for Action: Supplemental Research on COVID-19 Response and Recovery
Applications are due 8/5/20

This call for proposals (CFP) will provide supplemental research funding to teams that are already engaged in the study of a promising system alignment mechanism, with the objective of learning how this mechanism performs in addressing health and social needs during the COVID-19 pandemic. Eligible teams must have an active or recently completed research study (within 12 months of application submission) that can be extended through the use of supplemental research funding.

XPRIZE Rapid COVID Testing
Applications are due 8/31/2020

• The XPRIZE Foundation has launched a $5 million dollar, 6-month competition to develop faster, cheaper, and easier to use COVID-19 testing methods at scale. The winning teams will develop COVID-19 tests that are radically affordable compared to what’s currently available on the market. For about the price of a latte, the tests will be equal to (or better than) commercial offerings at measuring sensitivity, specificity, and limit of detection, with a maximum turnaround time of 12-hours from sample to result. The winning teams will also be able to successfully deploy and conduct a minimum of 500 tests per week at a live testing site within 60 days, and have the potential to scale their solutions to thousands of tests per week.

Junior Faculty Research Grants for the Study of Lung Cancer and COVID-19 Infection (The LungAmbition Alliance)
Application Portal Closes: 09/15/2020

• Grant program to support lung cancer research related to Lung Cancer and COVID-19 Infection. The purpose of this program is to fund groundbreaking research related to COVID-19 infected lung cancer patients. The intent of the support is to allow junior faculty researchers, as defined as fewer than 7 years in a faculty position after training, to obtain preliminary data that will enable them to successfully compete for national peer-reviewed grant support.
• The objective of this program is to support research by new investigators in epidemiology, pathology, imaging, immuno-biology and immune biomarkers, and translational science in COVID-19 positive lung cancer patients. Ultimately, the aim is to improve the quality of care and the outcomes for these patients.
• The minimum funding for the award will be $50,000. No more than 25% of the requested budget may be used for an Awardee’s salary and/or fringe benefits. No Award budget may be used to fund the purchase of permanent equipment. No indirect costs are provided. Any unused Award funds at the conclusion of the study period will be returned to the study sponsor.

March of Dimes 2020 COVID-19 Fund
Applications are due 9/4/20

• Supports (1) studies that examine clinical and socio-demographic predictors of perinatal health outcomes and treatments associated with COVID-19 for the mom-baby dyad and (2) studies examining the role of antibody testing in birth planning and postpartum care, sustainability of antibodies/immunity in mom-baby dyad, the viability of passive immunity through breastmilk, and mom-to-baby contact.

The COVID-19 Symptom Data Challenge

In partnership with Facebook Data for Good, the Delphi Group at Carnegie Mellon University (CMU), the Joint Program on Survey Methodology at the University of Maryland (UMD), the Duke Margolis Center for Health Policy, and Resolve to Save Lives, an initiative of Vital Strategies

Finalist Prizes (1st Place is $50,000; 2nd Place (runner up) is $25,000)

Can you develop a novel analytic approach that uses the CMU/UMD COVID-19 Symptom Survey data to enable earlier detection and improved situational awareness of the outbreak by public health authorities and the general public? Phase I submissions are due by September 29th, 2020 11:59 PM ET.

 Merck Research Grants for Pandemic Preparedness

Submissions will be accepted until 31 August 2020 23:59 CEST

• Merck is offering a grant comprising up to 250,000 €/year for 3 years with the option of extension. Proposals will be considered that leverage technological solutions to be more prepared for pandemic outbreaks or solutions that could help to fight emerging viral infections. 

Christopher & Dana Reeve Foundation new Quality of Life (QOL) Grants program

• LOI due October 13, 2020 (invited applications will be due November 20, 2020)
• The aim of the Reeve Foundation’s new Quality of Life (QOL) grants program is to address social isolation during the COVID-19 pandemic with the goal of enhancing connectedness of people living with paralysis and their caregivers to their communities and preventing adverse health outcomes.
• Though we are looking to the field for innovative ways to address the program’s aim and goals, funds may support programs and projects to:
  • Connect isolated individuals and remotely foster engagement and connection through
    • Virtual support groups
    • Online activities to help support self-care and stress management
    • Virtual and online adaptive physical activity and health promotion programs
    • Art sessions
    • Gaming
  • Adapt services or create new services to continue to support and engage family caregivers
  • Facilitate connection through the use of technology, including
    • Increasing access to internet, broadband service, and tablets (via loan closets)
  • Provide programs with online opportunities for volunteering (Volunteering has been shown to have many positive health benefits)
  • Create strategies to strengthen and/or build social networks
  • Provide access to tools and resources to help people remain connected and engaged
• It is expected that between six to ten grants will be awarded within the range of $25,000-$50,000.

Johnson & Johnson Nurses Innovate QuickFire Challenge in COVID-19 Patient Care together with the American Organization for Nursing LeadershipTM (AONL) and the Society of Nurse Scientists, Innovators, Entrepreneurs, & Leaders (SONSIEL). Nurses from around the world are invited to submit ideas aiming to improve COVID-19 patient care.

• Applications close on September 29, 2020
• We are looking for nurse-led ideas from nurses and nursing students around the world focused on improving COVID-19 patient care, with specific interest in, for example: facilitating remote patient monitoring and communications, data and reporting, resiliency and self-care, supporting a safe return to work or school, supporting sharing of best practices, and addressing racial disparities and inequities in healthcare.
• Potential nurse-led solutions will be evaluated by a panel of independent nurse reviewers and judges on their ability to meet the following criteria: Potential impact on transforming human health; Uniqueness of the idea; Feasibility of the idea; Thoroughness of approach; Identification of key resources and plan to further idea
• Areas of interest: Treatment protocols; Health technologies; Medical devices; Treatment pproaches; Consumer products; Community health approaches; Screening tools

State and Community-Based COVID-19 Testing (bid number ERFQ30034902100092) 
Applications are due 8/5/2020

• MissouriBUYS Statewide eProcurement System website​

Schmidt Futures The Futures Forum on Learning: Tools Competition
Description: The Futures Forum on Learning: Tools Competition (“Tools Competition”) invites teachers, students, researchers, technologists, and ed tech leaders to propose a tool, technology, platform, or research project that can accelerate recovery from COVID-19-related learning loss for students between grades K-12, and advance the field of learning engineering.

Topics: Solutions should aim to address one of the problem areas:

• Increase the number of students who are reading by 3rd grade
• Increase the number of students on track in middle-school math
• Expand the number of students gaining data and computer science skills in high school
• Driving more students into college through academic and nonacademic supports
• Another pressing learning goal identified by the team that is related to COVID-19

Due Dates: One-page concept description due 9/18/2020; detailed proposal due 10/26/2020.

Budget: Applicants will request an award on one of three tracks: $25,000 and under, $25,000-$100,000, and $100,000-$250,000

FSFW Health, Science, and Technology Request for Proposals
Topic: COVID-19, Smoking, and Nicotine Research

• Applications due December 15, 2020 5 PM UK Greenwich Mean Time
• Scoping / pre-clinical studies: Up to US$ 150,000 for up to 3 months
• Epidemiological studies: Up to US$ 250,000 for 3 to 6 months
• Clinical studies: Up to US$ 500,000 for up to 1 year
• The Foundation for a Smoke-free World is seeking to conduct research at the nexus of COVID-19, smoking, and nicotine that will require significant collaboration and research efforts with outside experts and organizations. We seek to advance knowledge of value to science and policy in these areas. The selected organization(s) will implement a range of projects relevant to the global pandemic, including well-designed and comprehensive pre-clinical, clinical, and epidemiological studies, to better understand the associations between smoking and / or nicotine use, and COVID-19 infection and outcomes.
• To address current knowledge gaps, this RFP seeks to accelerate research in the following areas:
  • The impacts of tobacco and nicotine products on COVID-19 outcomes
  • Opportunities for intervention to prevent or reduce COVID-19 infection, hospitalization, and disease progression
  • Interventions to promote healthier lifestyles (including but not restricted to nicotine use) in the wake of the pandemic

Foundation for Women’s Cancer Diversity and Inclusion Health Equity Research Grant

• Abstract due 09/21/2020; Full proposal due 11/25/2020
• Research among diverse populations has demonstrated disparities in treatment outcomes, access to care, genetic testing rates, and disease survival across many diseases. This new Diversity and Health Equity Research Grant is a one-year project where the funding is available for two $75,000 Research grants.
• The purpose of this award is to support research to understand and eliminate inequities in cancer care, specifically related to differential outcomes experienced by women from underserved or marginalized populations with gynecologic cancer, as well as to increase representation of underrepresented groups in gynecologic oncology as a strategy to achieve health equity for underserved women. Those eligible for applying are those who propose a study focused on a marginalized group, or those who identify as being from an under-represented group within the field of research.
• This year priority consideration will be given to proposals addressing health disparities in the context of gynecologic cancers related to the COVID-19 pandemic.

Pfizer COVID-19 Vaccine Patient Education: Addressing Vaccine Hesitancy

• Grant Application deadline is 02/10/2021. The total available budget related to this RFP is $500,000 USD; the expected approximate range of grant awards: $10,000 to $100,000 USD. Pfizer will consider larger grants depending on the size and scope of the program, but smaller grants for local and regional programs are a priority.
• Through this RFP it is our intent to support patient education programs designed to increase the understanding and familiarity with COVID-19 and COVID-19 vaccination among the general population. Of particular interest are educational programs that focus on reaching the medically underserved and other under-immunized populations including those in both rural and urban settings.
• All activity types will be considered, though given the current circumstances, virtual and digital activities will be prioritized. This includes applications to repurpose existing educational resources into easy-to-use and easy-to-access delivery formats (e.g. mobile apps.) We will also consider applications repurposing education or training resources that currently exist in one language but could be modified and translated to other languages and rolled out in different geographies.
• It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

PCORI Phased Large Awards in Comparative Effectiveness Research (PLACER)
LOI applications are due 9/29/2020. Full applications are due 1/12/2021.

• This PCORI funding announcement invites applications for high-quality comparative effectiveness research (CER) projects that will examine a critical patient-centered research question that is also relevant to decision makers and other stakeholders. For this PFA, investigators should propose an individual-level or cluster randomized controlled trial of significant scale and scope, requiring funding in excess of $10 million in direct costs. The proposed trials should address important decisional dilemmas that require important new evidence about the comparative effectiveness of available interventions.

Christopher and Dana Reeve Foundation Quality of Life Grants – COVID-19: Addressing Social Isolation Grants (WUSTL Key Required) Internal Selection deadline is 02/11/2021 (OPEN); Applications due to Foundation 03/15/2021

• The aim of the Reeve Foundation’s new grants program is to address social isolation during the COVID-19 pandemic with the goal of enhancing connectedness of people living with paralysis and their caregivers to their communities and preventing adverse health outcomes. Though they are looking to the field for innovative ways to address the program’s aim and goals, funds may support programs and projects to:
  • Connect isolated individuals and remotely foster engagement and connection through
  • Virtual support groups
  • Online activities to help support self-care and stress management
  • Virtual and online adaptive physical activity and health promotion programs
  • Art sessions
  • Gaming
• Adapt services or create new services to continue to support and engage family caregivers
• Facilitate connection through the use of technology, including
  • Increasing access to internet, broadband service, and tablets (via loan closets)
• Provide programs with online opportunities for volunteering (Volunteering has been shown to have many positive health benefits)
• Create strategies to strengthen and/or build social networks
• Provide access to tools and resources to help people remain connected and engaged

SFARI Maternal COVID-19 as a potential risk for autism: Supplemental funding for ongoing pregnancy cohorts (Application deadline is March 12, 2021)

• Grants awarded through this RFA will supplement funding from other agencies for ongoing pregnancy cohorts to broaden biospecimen collection and to extend post-natal family tracking. These cohorts and biospecimen collections can be leveraged in future research to understand the effects of gestational infection and inflammation on autism risk in children.
• SFARI invites your proposal for funding to extend biospecimen collection and post-natal family tracking in your prospective pregnancy cohort study. A total award period of three years is planned. We anticipate that the budget for Year 1 would primarily support biospecimen collection, but also processing and storage, if needed. The budgets for Years 2 and 3 would primarily support family tracking to ensure that they can be contacted for child clinical assessment at 2–3 years of age. Funding for Years 2 and 3 will be dependent on successful recruitment of participants and collection of biospecimens in Year 1.
• The maximum budget is $250,000 for projects recruiting at a single site, and $400,000 for projects recruiting at two or more sites.

Engagement Award Special Cycle: Building Capacity for PCOR/CER for Topics Related to COVID-19

Full Proposals are due May 24, 2021 (5 PM ET)

• This Eugene Washington PCORI Engagement Awards Special Cycle Funding Announcement—Building Capacity for PCOR/CER for Topics Related to COVID-19 is a research support – not research—special funding opportunity for projects up to 18 months in duration and up to $200,000 in total costs. The length of the project period and budget amount must be justified by the level of activity that will occur during the project and all projects must be at least 12 months in duration.
• This special funding opportunity will support projects that enable organizations and communities to build their capacity and skills to participate across all phases of the PCOR/CER process on topics that address health outcomes related to COVID-19. Projects will also provide an understanding of the impact of stakeholder engagement strategies within different settings and stakeholder groups focused on this special area of interest.
• In the context of the Engagement Awards program, capacity building to support research refers to the following types of projects:
  • Projects that focus on building the knowledge, competencies, and abilities of patients and other stakeholders to be meaningful partners in PCOR/CER with researchers throughout the research process, from topic selection through design and conduct of research to dissemination or implementation of results.
  • Projects that strengthen the skills of researchers to be better partners with patients and other stakeholders involved in PCOR/CER.
  • Projects that support the expansion of use or adoption of existing engagement tools and resources to build capacity for PCOR/CER in a new population or geographic area.
• This is an opportunity to explore and address the urgent and unique needs to build capacity for stakeholder engagement in PCOR/CER specifically related to:
  • Long-term effects of post-acute COVID-19;
  • Impact of COVID-19 on disproportionately affected populations;
  • Impact of COVID-19 on social isolation and loneliness (mental health and well-being); and
  • Engaging, educating, and promoting informed decision making around COVID-19 vaccines.
• Other relevant topics related to COVID-19 health outcomes with appropriate justification will also be considered.

National Geographic Society COVID-19 Science Fund

Statement of interest will be accepted through 11:59 PM EDT March 31, 2021.

• In response to worldwide disruptions from the COVID-19 pandemic, the National Geographic Society is providing funding for projects focused on how humanity and the natural world have reacted to and are living through the unparalleled circumstances created by COVID-19 in order to better understand how this pandemic—or the threat of another—will shape our world for years to come. Proposed projects should seek to better understand and/or provide solutions to the situations created or magnified by the pandemic, thereby helping us to understand and address the challenges and changes of living in a COVID-19 world. This fund invites research, conservation, and technology projects on the following two (2) topics; below are examples of the types of questions and projects that the Society would like to receive:
• Community-based and inclusive conservation.
  • How have community and grassroots organizations been impacted by COVID-19?
  • How have organizations continued their conservation activities during the pandemic? What types of new models or innovative approaches to conservation are being tried?
  • How are local communities that have depended on external visitors or revenues for their livelihoods and other conservation activities, adapting to the new context?
  • With people unable to afford to stay in cities, how are rural communities shaped and changed by people returning?
  • Given the ongoing economic crises due to COVID-19, what lessons can be applied post pandemic to support sustainable and just economic recovery in areas with high biodiversity and/or cultural heritage resources?
• Impacts of tourism changes on cultural heritage sites and wildlife.
  • How have changes in global and/or domestic tourism affected wildlife, protected area management, cultural heritage site conservation, and the livelihoods and well-being of nearby communities?
  • What lessons can be applied for when/if tourism returns?
  • How has tourism been re-invented during the pandemic? What types of new models or innovative approaches to tourism are being tried?
  • Some natural and cultural heritage areas may have seen increased domestic and local tourism as a result of the pandemic – what are the impacts, if any?

• Only applications that propose activity in the applicant’s country of residence will be considered. Budgets: Funding requests of up to $50,000 will be accepted for review. Applicants will receive decisions on their statement of interest by April 8, 2021. Full applications will be due by 11:59pm EDT May 19, 2021. Applicants will receive a funding decision in summer 2021. Proposed project activities should occur after funding decisions are made.

Longer Life Foundation Call for Applications: Developmental Research Awards – Letters of Intent are due by Midnight of February 19, 2021. Call for Applications  

• An interactive session with Dr. Dominic Reeds, Director of the Longer Life Center, and Dr. Dan Zimmerman, Managing Director of the Longer Life Foundation, will be held on Wednesday, January 27, 2021 from 9:00 – 10:00 AM via Zoom.  Registration is required (register here). This Q&A session is offered to provide feedback on potential ideas for award applications, as well as technical details about the grant application and review processes.
• The Longer Life Foundation’s mission is to fund and support the study of factors that either predict the mortality and morbidity of selected populations or influence improvements in longevity, health, and wellness.
• These grants are specifically for either junior investigators who are interested in longevity-related research and have yet to obtain independent funding, or for established investigators who are developing a new direction in research on determinants of health and longevity. These awards provide up to $50,000 direct costs per year for up to 2 years to support these missions. Further, hands-on mentorship to assist scientific development is provided to junior faculty who are beginning their research careers. These grants have proven highly effective at generating pilot data for junior investigators and in allowing them to successfully compete for funding from national agencies. Please note: in the updated RFP, the project ideas have been expanded to include a few COVID-related topics.
  • Pandemic risk modeling and ways of mitigating catastrophic outcomes
  • Long-term impact of COVID-19 on mortality and morbidity outcomes

Mozilla Open Source Support Program (MOSS) COVID-19 Solutions Fund
Applications are accepted on a rolling basis; Closed June 2020.

• Mozilla will provide awards of up to $50,000 each to open source technology projects which are responding to the COVID-19 pandemic in some way. As part of the COVID-19 Solutions Fund, we will accept applications that are hardware (e.g., an open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator), as well as software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation).

FastGrants – Fast Funding for COVID-19 Science
Applications accepted on a rolling basis – current on hold due to large number of application received.

• Science funding mechanisms are too slow in normal times and may be much too slow during the COVID-19 pandemic. Fast Grants are an effort to correct this. If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 48 hours. If we approve the grant, you’ll receive payment as quickly as your university can receive it

PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research
Applications accepted on a rolling basis; Closed July 17, 2020

• PCORI seeks investigator-initiated proposals to address the COVID-19 public health crisis through enhancements of currently funded PCORI research awards. Only PCORI-funded principal investigators with active research project funding contracts are eligible to submit a proposal in response to this announcement.

Wellcome Trust – Epidemic Preparedness: COVID-19 Funding Call
Application period is closed.

• Applicants must be able to swiftly begin to investigate new approaches for preventing and controlling COVID-19. Proposals should focus on helping low- and middle-income countries prepare for and deal with the epidemic. Eligible applicants are researchers with a PhD or the equivalent, and significant postdoctoral research experience. These awards are open to individuals or teams of up to five members. Applicants can be based anywhere in the world (apart from mainland China). Wellcome Trust particularly encourages applications from lead applicants based in low- and middle-income countries.

---